id	sid	tid	token	lemma	pos
iajs-2646	1	1	special	special	ADJ
iajs-2646	1	2	issue	issue	NOUN
iajs-2646	1	3	1220	1220	NUM
iajs-2646	1	4	icpasih	icpasih	NOUN
iajs-2646	1	5	ibn	ibn	PROPN
iajs-2646	1	6	al	al	PROPN
iajs-2646	1	7	-	-	PUNCT
iajs-2646	1	8	haitham	haitham	PROPN
iajs-2646	1	9	journal	journal	PROPN
iajs-2646	1	10	for	for	ADP
iajs-2646	1	11	pure	pure	ADJ
iajs-2646	1	12	and	and	CCONJ
iajs-2646	1	13	applied	apply	VERB
iajs-2646	1	14	science	science	NOUN
iajs-2646	1	15	https://doi.org/	https://doi.org/	NOUN
iajs-2646	1	16	10.30526/2021.ihicpas.2646	10.30526/2021.ihicpas.2646	NOUN
iajs-2646	1	17	for	for	ADP
iajs-2646	1	18	more	more	ADJ
iajs-2646	1	19	information	information	NOUN
iajs-2646	1	20	about	about	ADP
iajs-2646	1	21	the	the	DET
iajs-2646	1	22	conference	conference	NOUN
iajs-2646	1	23	please	please	INTJ
iajs-2646	1	24	visit	visit	VERB
iajs-2646	1	25	the	the	DET
iajs-2646	1	26	websites	website	NOUN
iajs-2646	1	27	:	:	PUNCT
iajs-2646	1	28	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2646	1	29	b	b	NOUN
iajs-2646	2	1	i	i	NOUN
iajs-2646	2	2	o	o	NOUN
iajs-2646	3	1	l	l	NOUN
iajs-2646	3	2	o	o	X
iajs-2646	3	3	g	g	NOUN
iajs-2646	3	4	y	y	PROPN
iajs-2646	3	5	|	|	ADV
iajs-2646	3	6	23	23	NUM
iajs-2646	3	7	estimation	estimation	NOUN
iajs-2646	3	8	of	of	ADP
iajs-2646	3	9	some	some	DET
iajs-2646	3	10	biomarkers	biomarker	NOUN
iajs-2646	3	11	and	and	CCONJ
iajs-2646	3	12	cholesterol	cholesterol	NOUN
iajs-2646	3	13	/	/	SYM
iajs-2646	3	14	hdl	hdl	PROPN
iajs-2646	3	15	ratio	ratio	NOUN
iajs-2646	3	16	to	to	PART
iajs-2646	3	17	predict	predict	VERB
iajs-2646	3	18	the	the	DET
iajs-2646	3	19	risk	risk	NOUN
iajs-2646	3	20	of	of	ADP
iajs-2646	3	21	cardiovascular	cardiovascular	ADJ
iajs-2646	3	22	disease	disease	NOUN
iajs-2646	3	23	in	in	ADP
iajs-2646	3	24	rheumatoid	rheumatoid	NOUN
iajs-2646	3	25	arthritis	arthritis	NOUN
iajs-2646	3	26	patients	patient	NOUN
iajs-2646	3	27	abstract	abstract	ADV
iajs-2646	3	28	rheumatoid	rheumatoid	VERB
iajs-2646	3	29	arthritis	arthritis	NOUN
iajs-2646	3	30	(	(	PUNCT
iajs-2646	3	31	ar	ar	NOUN
iajs-2646	3	32	)	)	PUNCT
iajs-2646	3	33	is	be	AUX
iajs-2646	3	34	one	one	NUM
iajs-2646	3	35	of	of	ADP
iajs-2646	3	36	the	the	DET
iajs-2646	3	37	chronic	chronic	ADJ
iajs-2646	3	38	diseases	disease	NOUN
iajs-2646	3	39	resulting	result	VERB
iajs-2646	3	40	in	in	ADP
iajs-2646	3	41	many	many	ADJ
iajs-2646	3	42	complications	complication	NOUN
iajs-2646	3	43	such	such	ADJ
iajs-2646	3	44	as	as	ADP
iajs-2646	3	45	cardiovascular	cardiovascular	ADJ
iajs-2646	3	46	disease	disease	NOUN
iajs-2646	3	47	(	(	PUNCT
iajs-2646	3	48	cvd	cvd	PROPN
iajs-2646	3	49	)	)	PUNCT
iajs-2646	3	50	.	.	PUNCT
iajs-2646	4	1	any	any	DET
iajs-2646	4	2	change	change	NOUN
iajs-2646	4	3	in	in	ADP
iajs-2646	4	4	the	the	DET
iajs-2646	4	5	lipid	lipid	NOUN
iajs-2646	4	6	profiles	profile	NOUN
iajs-2646	4	7	and	and	CCONJ
iajs-2646	4	8	myocardial	myocardial	ADJ
iajs-2646	4	9	markers	marker	NOUN
iajs-2646	4	10	indicates	indicate	VERB
iajs-2646	4	11	cardiovascular	cardiovascular	ADJ
iajs-2646	4	12	disease	disease	NOUN
iajs-2646	4	13	risk	risk	NOUN
iajs-2646	4	14	,	,	PUNCT
iajs-2646	4	15	so	so	CCONJ
iajs-2646	4	16	this	this	DET
iajs-2646	4	17	study	study	NOUN
iajs-2646	4	18	is	be	AUX
iajs-2646	4	19	designed	design	VERB
iajs-2646	4	20	to	to	PART
iajs-2646	4	21	monitor	monitor	VERB
iajs-2646	4	22	the	the	DET
iajs-2646	4	23	pattern	pattern	NOUN
iajs-2646	4	24	of	of	ADP
iajs-2646	4	25	lipid	lipid	ADJ
iajs-2646	4	26	profiles	profile	NOUN
iajs-2646	4	27	and	and	CCONJ
iajs-2646	4	28	myocardial	myocardial	ADJ
iajs-2646	4	29	markers	marker	NOUN
iajs-2646	4	30	in	in	ADP
iajs-2646	4	31	newly	newly	ADV
iajs-2646	4	32	diagnosed	diagnose	VERB
iajs-2646	4	33	ra	ra	NOUN
iajs-2646	4	34	patients	patient	NOUN
iajs-2646	4	35	.	.	PUNCT
iajs-2646	5	1	blood	blood	NOUN
iajs-2646	5	2	samples	sample	NOUN
iajs-2646	5	3	were	be	AUX
iajs-2646	5	4	collected	collect	VERB
iajs-2646	5	5	from	from	ADP
iajs-2646	5	6	70	70	NUM
iajs-2646	5	7	iraqi	iraqi	ADJ
iajs-2646	5	8	patients	patient	NOUN
iajs-2646	5	9	newly	newly	ADV
iajs-2646	5	10	diagnosed	diagnose	VERB
iajs-2646	5	11	with	with	ADP
iajs-2646	5	12	rheumatoid	rheumatoid	NOUN
iajs-2646	5	13	arthritis	arthritis	NOUN
iajs-2646	5	14	(	(	PUNCT
iajs-2646	5	15	male	male	ADJ
iajs-2646	5	16	and	and	CCONJ
iajs-2646	5	17	female	female	NOUN
iajs-2646	5	18	)	)	PUNCT
iajs-2646	5	19	and	and	CCONJ
iajs-2646	5	20	30	30	NUM
iajs-2646	5	21	healthy	healthy	ADJ
iajs-2646	5	22	served	serve	VERB
iajs-2646	5	23	as	as	ADP
iajs-2646	5	24	control	control	NOUN
iajs-2646	5	25	.	.	PUNCT
iajs-2646	6	1	these	these	DET
iajs-2646	6	2	individuals	individual	NOUN
iajs-2646	6	3	were	be	AUX
iajs-2646	6	4	aged	age	VERB
iajs-2646	6	5	35	35	NUM
iajs-2646	6	6	-	-	SYM
iajs-2646	6	7	65	65	NUM
iajs-2646	6	8	years	year	NOUN
iajs-2646	6	9	.	.	PUNCT
iajs-2646	7	1	the	the	DET
iajs-2646	7	2	serum	serum	NOUN
iajs-2646	7	3	samples	sample	NOUN
iajs-2646	7	4	were	be	AUX
iajs-2646	7	5	obtained	obtain	VERB
iajs-2646	7	6	to	to	PART
iajs-2646	7	7	determine	determine	VERB
iajs-2646	7	8	myocardial	myocardial	ADJ
iajs-2646	7	9	markers	marker	NOUN
iajs-2646	7	10	;	;	PUNCT
iajs-2646	7	11	included	include	VERB
iajs-2646	7	12	troponin	troponin	PROPN
iajs-2646	7	13	,	,	PUNCT
iajs-2646	7	14	creatinine	creatinine	NOUN
iajs-2646	7	15	kinase	kinase	PROPN
iajs-2646	7	16	(	(	PUNCT
iajs-2646	7	17	ck	ck	PROPN
iajs-2646	7	18	)	)	PUNCT
iajs-2646	7	19	,	,	PUNCT
iajs-2646	7	20	lactate	lactate	NOUN
iajs-2646	7	21	dehydrogenase	dehydrogenase	NOUN
iajs-2646	7	22	(	(	PUNCT
iajs-2646	7	23	ldh	ldh	NOUN
iajs-2646	7	24	)	)	PUNCT
iajs-2646	7	25	,	,	PUNCT
iajs-2646	7	26	and	and	CCONJ
iajs-2646	7	27	glutamic	glutamic	ADJ
iajs-2646	7	28	oxaloacetic	oxaloacetic	ADJ
iajs-2646	7	29	transaminase	transaminase	NOUN
iajs-2646	7	30	got	get	VERB
iajs-2646	7	31	;	;	PUNCT
iajs-2646	7	32	and	and	CCONJ
iajs-2646	7	33	lipid	lipid	NOUN
iajs-2646	7	34	profiles	profile	NOUN
iajs-2646	7	35	;	;	PUNCT
iajs-2646	7	36	such	such	ADJ
iajs-2646	7	37	as	as	ADP
iajs-2646	7	38	cholesterol	cholesterol	NOUN
iajs-2646	7	39	,	,	PUNCT
iajs-2646	7	40	triglyceride	triglyceride	ADJ
iajs-2646	7	41	,	,	PUNCT
iajs-2646	7	42	high	high	ADJ
iajs-2646	7	43	-	-	PUNCT
iajs-2646	7	44	density	density	NOUN
iajs-2646	7	45	lipoprotein	lipoprotein	ADJ
iajs-2646	7	46	(	(	PUNCT
iajs-2646	7	47	hdl	hdl	NOUN
iajs-2646	7	48	)	)	PUNCT
iajs-2646	7	49	,	,	PUNCT
iajs-2646	7	50	low	low	ADJ
iajs-2646	7	51	-	-	PUNCT
iajs-2646	7	52	density	density	NOUN
iajs-2646	7	53	lipoprotein	lipoprotein	ADJ
iajs-2646	7	54	(	(	PUNCT
iajs-2646	7	55	ldl	ldl	NOUN
iajs-2646	7	56	)	)	PUNCT
iajs-2646	7	57	,	,	PUNCT
iajs-2646	7	58	and	and	CCONJ
iajs-2646	7	59	very	very	ADV
iajs-2646	7	60	-	-	PUNCT
iajs-2646	7	61	low	low	ADJ
iajs-2646	7	62	-	-	PUNCT
iajs-2646	7	63	density	density	NOUN
iajs-2646	7	64	lipoprotein	lipoprotein	ADJ
iajs-2646	7	65	(	(	PUNCT
iajs-2646	7	66	vldl	vldl	NOUN
iajs-2646	7	67	)	)	PUNCT
iajs-2646	7	68	;	;	PUNCT
iajs-2646	7	69	using	use	VERB
iajs-2646	7	70	a	a	DET
iajs-2646	7	71	kit	kit	NOUN
iajs-2646	7	72	from	from	ADP
iajs-2646	7	73	roch	roch	PROPN
iajs-2646	7	74	(	(	PUNCT
iajs-2646	7	75	germany	germany	PROPN
iajs-2646	7	76	)	)	PUNCT
iajs-2646	7	77	,	,	PUNCT
iajs-2646	7	78	measured	measure	VERB
iajs-2646	7	79	automatically	automatically	ADV
iajs-2646	7	80	with	with	ADP
iajs-2646	7	81	minividas	minividas	PROPN
iajs-2646	7	82	,	,	PUNCT
iajs-2646	7	83	biomerieux	biomerieux	PROPN
iajs-2646	7	84	(	(	PUNCT
iajs-2646	7	85	france	france	PROPN
iajs-2646	7	86	)	)	PUNCT
iajs-2646	7	87	.	.	PUNCT
iajs-2646	8	1	no	no	DET
iajs-2646	8	2	differences	difference	NOUN
iajs-2646	8	3	between	between	ADP
iajs-2646	8	4	levels	level	NOUN
iajs-2646	8	5	of	of	ADP
iajs-2646	8	6	all	all	DET
iajs-2646	8	7	lipid	lipid	ADJ
iajs-2646	8	8	profiles	profile	NOUN
iajs-2646	8	9	and	and	CCONJ
iajs-2646	8	10	myocardial	myocardial	ADJ
iajs-2646	8	11	markers	marker	NOUN
iajs-2646	8	12	in	in	ADP
iajs-2646	8	13	newly	newly	ADV
iajs-2646	8	14	diagnosed	diagnose	VERB
iajs-2646	8	15	ra	ra	PROPN
iajs-2646	8	16	patients	patient	NOUN
iajs-2646	8	17	compared	compare	VERB
iajs-2646	8	18	with	with	ADP
iajs-2646	8	19	the	the	DET
iajs-2646	8	20	healthy	healthy	ADJ
iajs-2646	8	21	group	group	NOUN
iajs-2646	8	22	were	be	AUX
iajs-2646	8	23	found	find	VERB
iajs-2646	8	24	as	as	ADV
iajs-2646	8	25	well	well	ADV
iajs-2646	8	26	as	as	SCONJ
iajs-2646	8	27	they	they	PRON
iajs-2646	8	28	were	be	AUX
iajs-2646	8	29	within	within	ADP
iajs-2646	8	30	the	the	DET
iajs-2646	8	31	normal	normal	ADJ
iajs-2646	8	32	values	value	NOUN
iajs-2646	8	33	,	,	PUNCT
iajs-2646	8	34	but	but	CCONJ
iajs-2646	8	35	interestingly	interestingly	ADV
iajs-2646	8	36	,	,	PUNCT
iajs-2646	8	37	the	the	DET
iajs-2646	8	38	cholesterol	cholesterol	PROPN
iajs-2646	8	39	/	/	SYM
iajs-2646	8	40	hdl	hdl	PROPN
iajs-2646	8	41	ratio	ratio	PROPN
iajs-2646	8	42	increased	increase	VERB
iajs-2646	8	43	significantly	significantly	ADV
iajs-2646	8	44	in	in	ADP
iajs-2646	8	45	ra	ra	PROPN
iajs-2646	8	46	patients	patient	NOUN
iajs-2646	8	47	comparing	compare	VERB
iajs-2646	8	48	with	with	ADP
iajs-2646	8	49	healthy	healthy	ADJ
iajs-2646	8	50	,	,	PUNCT
iajs-2646	8	51	so	so	SCONJ
iajs-2646	8	52	it	it	PRON
iajs-2646	8	53	could	could	AUX
iajs-2646	8	54	conclude	conclude	VERB
iajs-2646	8	55	that	that	SCONJ
iajs-2646	8	56	the	the	DET
iajs-2646	8	57	risk	risk	NOUN
iajs-2646	8	58	of	of	ADP
iajs-2646	8	59	cvd	cvd	PROPN
iajs-2646	8	60	could	could	AUX
iajs-2646	8	61	be	be	AUX
iajs-2646	8	62	increase	increase	VERB
iajs-2646	8	63	also	also	ADV
iajs-2646	8	64	among	among	ADP
iajs-2646	8	65	the	the	DET
iajs-2646	8	66	newly	newly	ADV
iajs-2646	8	67	diagnosed	diagnose	VERB
iajs-2646	8	68	of	of	ADP
iajs-2646	8	69	ra	ra	PROPN
iajs-2646	8	70	patients	patient	NOUN
iajs-2646	8	71	.	.	PUNCT
iajs-2646	9	1	moreover	moreover	ADV
iajs-2646	9	2	,	,	PUNCT
iajs-2646	9	3	the	the	DET
iajs-2646	9	4	cholesterol	cholesterol	PROPN
iajs-2646	9	5	/	/	SYM
iajs-2646	9	6	hdl	hdl	PROPN
iajs-2646	9	7	ratio	ratio	NOUN
iajs-2646	9	8	should	should	AUX
iajs-2646	9	9	be	be	AUX
iajs-2646	9	10	probably	probably	ADV
iajs-2646	9	11	included	include	VERB
iajs-2646	9	12	in	in	ADP
iajs-2646	9	13	a	a	DET
iajs-2646	9	14	model	model	NOUN
iajs-2646	9	15	to	to	PART
iajs-2646	9	16	predict	predict	VERB
iajs-2646	9	17	the	the	DET
iajs-2646	9	18	risk	risk	NOUN
iajs-2646	9	19	of	of	ADP
iajs-2646	9	20	cardiovascular	cardiovascular	ADJ
iajs-2646	9	21	disease	disease	NOUN
iajs-2646	9	22	for	for	ADP
iajs-2646	9	23	ra	ra	PROPN
iajs-2646	9	24	in	in	ADP
iajs-2646	9	25	addition	addition	NOUN
iajs-2646	9	26	to	to	ADP
iajs-2646	9	27	the	the	DET
iajs-2646	9	28	gender	gender	NOUN
iajs-2646	9	29	,	,	PUNCT
iajs-2646	9	30	age	age	NOUN
iajs-2646	9	31	at	at	ADP
iajs-2646	9	32	the	the	DET
iajs-2646	9	33	disease	disease	NOUN
iajs-2646	9	34	onset	onset	VERB
iajs-2646	9	35	,	,	PUNCT
iajs-2646	9	36	and	and	CCONJ
iajs-2646	9	37	severity	severity	NOUN
iajs-2646	9	38	markers	marker	NOUN
iajs-2646	9	39	of	of	ADP
iajs-2646	9	40	disease	disease	NOUN
iajs-2646	9	41	.	.	PUNCT
iajs-2646	10	1	keywords	keyword	NOUN
iajs-2646	10	2	:	:	PUNCT
iajs-2646	10	3	cardiovascular	cardiovascular	ADJ
iajs-2646	10	4	disease	disease	NOUN
iajs-2646	10	5	risk	risk	NOUN
iajs-2646	10	6	,	,	PUNCT
iajs-2646	10	7	myocardial	myocardial	ADJ
iajs-2646	10	8	biomarkers	biomarker	NOUN
iajs-2646	10	9	,	,	PUNCT
iajs-2646	10	10	lipid	lipid	NOUN
iajs-2646	10	11	profile	profile	NOUN
iajs-2646	10	12	,	,	PUNCT
iajs-2646	10	13	rheumatoid	rheumatoid	VERB
iajs-2646	10	14	arthritis	arthritis	NOUN
iajs-2646	10	15	disease	disease	NOUN
iajs-2646	10	16	,	,	PUNCT
iajs-2646	10	17	tc	tc	NOUN
iajs-2646	10	18	/	/	SYM
iajs-2646	10	19	hdl	hdl	NOUN
iajs-2646	10	20	ratio	ratio	NOUN
iajs-2646	10	21	.	.	PUNCT
iajs-2646	11	1	1	1	X
iajs-2646	11	2	.	.	X
iajs-2646	11	3	introduction	introduction	NOUN
iajs-2646	11	4	one	one	NUM
iajs-2646	11	5	of	of	ADP
iajs-2646	11	6	the	the	DET
iajs-2646	11	7	multiple	multiple	ADJ
iajs-2646	11	8	systemic	systemic	ADJ
iajs-2646	11	9	chronic	chronic	ADJ
iajs-2646	11	10	diseases	disease	NOUN
iajs-2646	11	11	is	be	AUX
iajs-2646	11	12	rheumatoid	rheumatoid	VERB
iajs-2646	11	13	arthritis	arthritis	NOUN
iajs-2646	11	14	(	(	PUNCT
iajs-2646	11	15	ra	ra	NOUN
iajs-2646	11	16	)	)	PUNCT
iajs-2646	11	17	which	which	PRON
iajs-2646	11	18	is	be	AUX
iajs-2646	11	19	usually	usually	ADV
iajs-2646	11	20	characterized	characterize	VERB
iajs-2646	11	21	as	as	ADP
iajs-2646	11	22	heterogeneous	heterogeneous	ADJ
iajs-2646	11	23	symptoms	symptom	NOUN
iajs-2646	11	24	,	,	PUNCT
iajs-2646	11	25	variable	variable	ADJ
iajs-2646	11	26	disease	disease	NOUN
iajs-2646	11	27	progression	progression	NOUN
iajs-2646	11	28	,	,	PUNCT
iajs-2646	11	29	and	and	CCONJ
iajs-2646	11	30	extracurricular	extracurricular	ADJ
iajs-2646	11	31	manifestations	manifestation	NOUN
iajs-2646	11	32	[	[	X
iajs-2646	11	33	1	1	NUM
iajs-2646	11	34	]	]	PUNCT
iajs-2646	11	35	.	.	PUNCT
iajs-2646	12	1	one	one	NUM
iajs-2646	12	2	of	of	ADP
iajs-2646	12	3	the	the	DET
iajs-2646	12	4	complications	complication	NOUN
iajs-2646	12	5	of	of	ADP
iajs-2646	12	6	this	this	DET
iajs-2646	12	7	disease	disease	NOUN
iajs-2646	12	8	is	be	AUX
iajs-2646	12	9	the	the	DET
iajs-2646	12	10	risk	risk	NOUN
iajs-2646	12	11	of	of	ADP
iajs-2646	12	12	developing	develop	VERB
iajs-2646	12	13	cardiovascular	cardiovascular	ADJ
iajs-2646	12	14	disease	disease	NOUN
iajs-2646	12	15	(	(	PUNCT
iajs-2646	12	16	cvd	cvd	PROPN
iajs-2646	12	17	)	)	PUNCT
iajs-2646	12	18	,	,	PUNCT
iajs-2646	12	19	where	where	SCONJ
iajs-2646	12	20	studies	study	NOUN
iajs-2646	12	21	indicate	indicate	VERB
iajs-2646	12	22	that	that	SCONJ
iajs-2646	12	23	the	the	DET
iajs-2646	12	24	risk	risk	NOUN
iajs-2646	12	25	of	of	ADP
iajs-2646	12	26	accidental	accidental	ADJ
iajs-2646	12	27	cardiovascular	cardiovascular	ADJ
iajs-2646	12	28	disease	disease	NOUN
iajs-2646	12	29	has	have	AUX
iajs-2646	12	30	increased	increase	VERB
iajs-2646	12	31	by	by	ADP
iajs-2646	12	32	48	48	NUM
iajs-2646	12	33	%	%	NOUN
iajs-2646	12	34	in	in	ADP
iajs-2646	12	35	previously	previously	ADV
iajs-2646	12	36	diagnosed	diagnose	VERB
iajs-2646	12	37	patients	patient	NOUN
iajs-2646	12	38	with	with	ADP
iajs-2646	12	39	rheumatoid	rheumatoid	NOUN
iajs-2646	12	40	arthritis	arthritis	NOUN
iajs-2646	12	41	compared	compare	VERB
iajs-2646	12	42	to	to	ADP
iajs-2646	12	43	the	the	DET
iajs-2646	12	44	individuals	individual	NOUN
iajs-2646	12	45	without	without	ADP
iajs-2646	12	46	ra	ra	PROPN
iajs-2646	13	1	[	[	X
iajs-2646	13	2	2	2	NUM
iajs-2646	13	3	]	]	PUNCT
iajs-2646	13	4	.	.	PUNCT
iajs-2646	14	1	clinical	clinical	ADJ
iajs-2646	14	2	reports	report	NOUN
iajs-2646	14	3	define	define	VERB
iajs-2646	14	4	many	many	ADJ
iajs-2646	14	5	markers	marker	NOUN
iajs-2646	14	6	that	that	PRON
iajs-2646	14	7	could	could	AUX
iajs-2646	14	8	detect	detect	VERB
iajs-2646	14	9	the	the	DET
iajs-2646	14	10	transaminases	transaminase	NOUN
iajs-2646	14	11	released	release	VERB
iajs-2646	14	12	from	from	ADP
iajs-2646	14	13	dying	die	VERB
iajs-2646	14	14	myocytes	myocyte	NOUN
iajs-2646	14	15	,	,	PUNCT
iajs-2646	14	16	help	help	VERB
iajs-2646	14	17	diagnosis	diagnosis	NOUN
iajs-2646	14	18	of	of	ADP
iajs-2646	14	19	myocardial	myocardial	ADJ
iajs-2646	14	20	infarction	infarction	NOUN
iajs-2646	14	21	,	,	PUNCT
iajs-2646	14	22	prognosis	prognosis	NOUN
iajs-2646	14	23	,	,	PUNCT
iajs-2646	14	24	and	and	CCONJ
iajs-2646	14	25	risk	risk	NOUN
iajs-2646	14	26	stratification	stratification	NOUN
iajs-2646	14	27	of	of	ADP
iajs-2646	14	28	enas	enas	PROPN
iajs-2646	14	29	abdul	abdul	PROPN
iajs-2646	14	30	kareem	kareem	PROPN
iajs-2646	14	31	jabbar	jabbar	PROPN
iajs-2646	14	32	enaskareemjj0@gmail.com	enaskareemjj0@gmail.com	PROPN
iajs-2646	14	33	department	department	PROPN
iajs-2646	14	34	of	of	ADP
iajs-2646	14	35	basic	basic	ADJ
iajs-2646	14	36	medical	medical	ADJ
iajs-2646	14	37	science	science	NOUN
iajs-2646	14	38	,	,	PUNCT
iajs-2646	14	39	college	college	NOUN
iajs-2646	14	40	of	of	ADP
iajs-2646	14	41	nursing	nursing	NOUN
iajs-2646	14	42	,	,	PUNCT
iajs-2646	14	43	university	university	NOUN
iajs-2646	14	44	of	of	ADP
iajs-2646	14	45	thi	thi	PROPN
iajs-2646	14	46	qar	qar	PROPN
iajs-2646	14	47	,	,	PUNCT
iajs-2646	14	48	iraq	iraq	PROPN
iajs-2646	14	49	.	.	PUNCT
iajs-2646	15	1	shaymaa	shaymaa	PROPN
iajs-2646	15	2	z.	z.	PROPN
iajs-2646	15	3	al	al	PROPN
iajs-2646	15	4	-	-	PUNCT
iajs-2646	15	5	rumaidh	rumaidh	NOUN
iajs-2646	15	6	shaymaaalrumaidh@gmail.com	shaymaaalrumaidh@gmail.com	PROPN
iajs-2646	16	1	college	college	PROPN
iajs-2646	16	2	of	of	ADP
iajs-2646	16	3	science	science	NOUN
iajs-2646	16	4	,	,	PUNCT
iajs-2646	16	5	university	university	NOUN
iajs-2646	16	6	of	of	ADP
iajs-2646	16	7	thi	thi	PROPN
iajs-2646	16	8	-	-	PUNCT
iajs-2646	16	9	qar	qar	PROPN
iajs-2646	16	10	,	,	PUNCT
iajs-2646	16	11	iraq	iraq	PROPN
iajs-2646	16	12	.	.	PUNCT
iajs-2646	17	1	jamela	jamela	PROPN
iajs-2646	17	2	jouda	jouda	PROPN
iajs-2646	17	3	jamela.jouda@uomustansir	jamela.jouda@uomustansir	PROPN
iajs-2646	17	4	iyaha.idu.iq	iyaha.idu.iq	PROPN
iajs-2646	17	5	department	department	NOUN
iajs-2646	17	6	of	of	ADP
iajs-2646	17	7	biology	biology	NOUN
iajs-2646	17	8	,	,	PUNCT
iajs-2646	17	9	college	college	NOUN
iajs-2646	17	10	of	of	ADP
iajs-2646	17	11	science	science	NOUN
iajs-2646	17	12	,	,	PUNCT
iajs-2646	17	13	mustansiriyiah	mustansiriyiah	PROPN
iajs-2646	17	14	university	university	PROPN
iajs-2646	17	15	,	,	PUNCT
iajs-2646	17	16	bagdad	bagdad	PROPN
iajs-2646	17	17	,	,	PUNCT
iajs-2646	17	18	iraq	iraq	PROPN
iajs-2646	17	19	.	.	PUNCT
iajs-2646	18	1	http://ihicps.com/	http://ihicps.com/	PROPN
iajs-2646	18	2	mailto:enaskareemjj0@gmail.com	mailto:enaskareemjj0@gmail.com	PROPN
iajs-2646	18	3	mailto:shaymaaalrumaidh@gmail.com	mailto:shaymaaalrumaidh@gmail.com	PROPN
iajs-2646	18	4	mailto:jamela.jouda@uomustansiriyaha.idu.iq	mailto:jamela.jouda@uomustansiriyaha.idu.iq	PROPN
iajs-2646	18	5	mailto:jamela.jouda@uomustansiriyaha.idu.iq	mailto:jamela.jouda@uomustansiriyaha.idu.iq	PROPN
iajs-2646	18	6	special	special	ADJ
iajs-2646	18	7	issue	issue	NOUN
iajs-2646	18	8	1220	1220	NUM
iajs-2646	18	9	icpasih	icpasih	NOUN
iajs-2646	18	10	ibn	ibn	PROPN
iajs-2646	18	11	al	al	PROPN
iajs-2646	18	12	-	-	PUNCT
iajs-2646	18	13	haitham	haitham	PROPN
iajs-2646	18	14	journal	journal	PROPN
iajs-2646	18	15	for	for	ADP
iajs-2646	18	16	pure	pure	ADJ
iajs-2646	18	17	and	and	CCONJ
iajs-2646	18	18	applied	apply	VERB
iajs-2646	18	19	science	science	NOUN
iajs-2646	18	20	https://doi.org/	https://doi.org/	NOUN
iajs-2646	18	21	10.30526/2021.ihicpas.2646	10.30526/2021.ihicpas.2646	NOUN
iajs-2646	18	22	for	for	ADP
iajs-2646	18	23	more	more	ADJ
iajs-2646	18	24	information	information	NOUN
iajs-2646	18	25	about	about	ADP
iajs-2646	18	26	the	the	DET
iajs-2646	18	27	conference	conference	NOUN
iajs-2646	18	28	please	please	INTJ
iajs-2646	18	29	visit	visit	VERB
iajs-2646	18	30	the	the	DET
iajs-2646	18	31	websites	website	NOUN
iajs-2646	18	32	:	:	PUNCT
iajs-2646	18	33	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2646	18	34	b	b	NOUN
iajs-2646	19	1	i	i	NOUN
iajs-2646	19	2	o	o	NOUN
iajs-2646	20	1	l	l	NOUN
iajs-2646	20	2	o	o	X
iajs-2646	20	3	g	g	NOUN
iajs-2646	20	4	y	y	PROPN
iajs-2646	21	1	|	|	ADV
iajs-2646	21	2	24	24	NUM
iajs-2646	21	3	patients	patient	NOUN
iajs-2646	21	4	with	with	ADP
iajs-2646	21	5	the	the	DET
iajs-2646	21	6	potential	potential	ADJ
iajs-2646	21	7	cardiovascular	cardiovascular	ADJ
iajs-2646	21	8	disease	disease	NOUN
iajs-2646	21	9	.	.	PUNCT
iajs-2646	22	1	these	these	DET
iajs-2646	22	2	markers	marker	NOUN
iajs-2646	22	3	included	include	VERB
iajs-2646	22	4	troponin	troponin	PROPN
iajs-2646	22	5	,	,	PUNCT
iajs-2646	22	6	creatinine	creatinine	NOUN
iajs-2646	22	7	kinase	kinase	PROPN
iajs-2646	22	8	(	(	PUNCT
iajs-2646	22	9	ck	ck	PROPN
iajs-2646	22	10	)	)	PUNCT
iajs-2646	22	11	,	,	PUNCT
iajs-2646	22	12	glutamic	glutamic	ADJ
iajs-2646	22	13	oxaloacetic	oxaloacetic	ADJ
iajs-2646	22	14	transaminase	transaminase	NOUN
iajs-2646	22	15	got	get	VERB
iajs-2646	22	16	,	,	PUNCT
iajs-2646	22	17	and	and	CCONJ
iajs-2646	22	18	lactate	lactate	NOUN
iajs-2646	22	19	dehydrogenase	dehydrogenase	NOUN
iajs-2646	22	20	(	(	PUNCT
iajs-2646	22	21	ldh	ldh	NOUN
iajs-2646	22	22	)	)	PUNCT
iajs-2646	22	23	.	.	PUNCT
iajs-2646	23	1	all	all	DET
iajs-2646	23	2	these	these	DET
iajs-2646	23	3	enzymes	enzyme	NOUN
iajs-2646	23	4	are	be	AUX
iajs-2646	23	5	released	release	VERB
iajs-2646	23	6	in	in	ADP
iajs-2646	23	7	different	different	ADJ
iajs-2646	23	8	quantities	quantity	NOUN
iajs-2646	23	9	by	by	ADP
iajs-2646	23	10	the	the	DET
iajs-2646	23	11	death	death	NOUN
iajs-2646	23	12	of	of	ADP
iajs-2646	23	13	muscle	muscle	NOUN
iajs-2646	23	14	cells	cell	NOUN
iajs-2646	23	15	,	,	PUNCT
iajs-2646	23	16	but	but	CCONJ
iajs-2646	23	17	the	the	DET
iajs-2646	23	18	research	research	NOUN
iajs-2646	23	19	continued	continue	VERB
iajs-2646	23	20	since	since	SCONJ
iajs-2646	23	21	the	the	DET
iajs-2646	23	22	sensitivity	sensitivity	NOUN
iajs-2646	23	23	and	and	CCONJ
iajs-2646	23	24	specificity	specificity	NOUN
iajs-2646	23	25	for	for	ADP
iajs-2646	23	26	myocardial	myocardial	ADJ
iajs-2646	23	27	necrosis	necrosis	NOUN
iajs-2646	23	28	fuels	fuel	NOUN
iajs-2646	23	29	are	be	AUX
iajs-2646	23	30	lacking	lack	VERB
iajs-2646	23	31	[	[	X
iajs-2646	23	32	3	3	NUM
iajs-2646	23	33	]	]	PUNCT
iajs-2646	23	34	.	.	PUNCT
iajs-2646	24	1	many	many	ADJ
iajs-2646	24	2	studies	study	NOUN
iajs-2646	24	3	have	have	AUX
iajs-2646	24	4	reported	report	VERB
iajs-2646	24	5	lipid	lipid	ADJ
iajs-2646	24	6	abnormalities	abnormality	NOUN
iajs-2646	24	7	in	in	ADP
iajs-2646	24	8	previously	previously	ADV
iajs-2646	24	9	diagnosed	diagnose	VERB
iajs-2646	24	10	ra	ra	PROPN
iajs-2646	24	11	patients	patient	NOUN
iajs-2646	24	12	[	[	X
iajs-2646	24	13	4	4	NUM
iajs-2646	24	14	,	,	PUNCT
iajs-2646	24	15	5	5	NUM
iajs-2646	24	16	,	,	PUNCT
iajs-2646	24	17	6	6	NUM
iajs-2646	24	18	]	]	SYM
iajs-2646	24	19	one	one	NUM
iajs-2646	24	20	of	of	ADP
iajs-2646	24	21	the	the	DET
iajs-2646	24	22	traditional	traditional	ADJ
iajs-2646	24	23	cardiovascular	cardiovascular	ADJ
iajs-2646	24	24	risk	risk	NOUN
iajs-2646	24	25	factors	factor	NOUN
iajs-2646	24	26	[	[	X
iajs-2646	24	27	7	7	NUM
iajs-2646	24	28	]	]	PUNCT
iajs-2646	24	29	.	.	PUNCT
iajs-2646	25	1	dyslipidemia	dyslipidemia	NOUN
iajs-2646	25	2	is	be	AUX
iajs-2646	25	3	observed	observe	VERB
iajs-2646	25	4	in	in	ADP
iajs-2646	25	5	these	these	DET
iajs-2646	25	6	patients	patient	NOUN
iajs-2646	25	7	differently	differently	ADV
iajs-2646	25	8	than	than	ADP
iajs-2646	25	9	in	in	ADP
iajs-2646	25	10	the	the	DET
iajs-2646	25	11	general	general	ADJ
iajs-2646	25	12	population	population	NOUN
iajs-2646	25	13	,	,	PUNCT
iajs-2646	25	14	including	include	VERB
iajs-2646	25	15	total	total	ADJ
iajs-2646	25	16	cholesterol	cholesterol	NOUN
iajs-2646	25	17	and	and	CCONJ
iajs-2646	25	18	hdl	hdl	NOUN
iajs-2646	26	1	[	[	X
iajs-2646	26	2	8	8	NUM
iajs-2646	26	3	,	,	PUNCT
iajs-2646	26	4	9	9	NUM
iajs-2646	26	5	]	]	PUNCT
iajs-2646	26	6	.	.	PUNCT
iajs-2646	27	1	since	since	SCONJ
iajs-2646	27	2	the	the	DET
iajs-2646	27	3	ratio	ratio	NOUN
iajs-2646	27	4	of	of	ADP
iajs-2646	27	5	disproportionate	disproportionate	ADJ
iajs-2646	27	6	between	between	ADP
iajs-2646	27	7	tc	tc	NOUN
iajs-2646	27	8	and	and	CCONJ
iajs-2646	27	9	hdl	hdl	PROPN
iajs-2646	27	10	levels	level	NOUN
iajs-2646	27	11	increases	increase	VERB
iajs-2646	27	12	the	the	DET
iajs-2646	27	13	index	index	NOUN
iajs-2646	27	14	of	of	ADP
iajs-2646	27	15	atherogenic	atherogenic	ADJ
iajs-2646	27	16	,	,	PUNCT
iajs-2646	27	17	it	it	PRON
iajs-2646	27	18	is	be	AUX
iajs-2646	27	19	an	an	DET
iajs-2646	27	20	important	important	ADJ
iajs-2646	27	21	predictive	predictive	ADJ
iajs-2646	27	22	sign	sign	NOUN
iajs-2646	27	23	of	of	ADP
iajs-2646	27	24	cvd	cvd	PROPN
iajs-2646	28	1	[	[	X
iajs-2646	28	2	1	1	NUM
iajs-2646	28	3	]	]	PUNCT
iajs-2646	28	4	.	.	PUNCT
iajs-2646	29	1	these	these	DET
iajs-2646	29	2	pieces	piece	NOUN
iajs-2646	29	3	of	of	ADP
iajs-2646	29	4	evidence	evidence	NOUN
iajs-2646	29	5	proved	prove	VERB
iajs-2646	29	6	that	that	SCONJ
iajs-2646	29	7	the	the	DET
iajs-2646	29	8	previously	previously	ADV
iajs-2646	29	9	diagnosed	diagnose	VERB
iajs-2646	29	10	patients	patient	NOUN
iajs-2646	29	11	with	with	ADP
iajs-2646	29	12	rd	rd	NOUN
iajs-2646	29	13	could	could	AUX
iajs-2646	29	14	have	have	VERB
iajs-2646	29	15	lipid	lipid	NOUN
iajs-2646	29	16	and	and	CCONJ
iajs-2646	29	17	myocardial	myocardial	ADJ
iajs-2646	29	18	markers	marker	NOUN
iajs-2646	29	19	abnormalities	abnormality	NOUN
iajs-2646	29	20	while	while	SCONJ
iajs-2646	29	21	to	to	ADP
iajs-2646	29	22	our	our	PRON
iajs-2646	29	23	knowledge	knowledge	NOUN
iajs-2646	29	24	there	there	PRON
iajs-2646	29	25	is	be	VERB
iajs-2646	29	26	no	no	DET
iajs-2646	29	27	research	research	NOUN
iajs-2646	29	28	study	study	NOUN
iajs-2646	29	29	on	on	ADP
iajs-2646	29	30	these	these	DET
iajs-2646	29	31	markers	marker	NOUN
iajs-2646	29	32	in	in	ADP
iajs-2646	29	33	newly	newly	ADV
iajs-2646	29	34	diagnosed	diagnose	VERB
iajs-2646	29	35	patients	patient	NOUN
iajs-2646	29	36	with	with	ADP
iajs-2646	29	37	rd	rd	PROPN
iajs-2646	29	38	,	,	PUNCT
iajs-2646	29	39	so	so	SCONJ
iajs-2646	29	40	this	this	DET
iajs-2646	29	41	study	study	NOUN
iajs-2646	29	42	is	be	AUX
iajs-2646	29	43	designed	design	VERB
iajs-2646	29	44	to	to	PART
iajs-2646	29	45	monitor	monitor	VERB
iajs-2646	29	46	the	the	DET
iajs-2646	29	47	pattern	pattern	NOUN
iajs-2646	29	48	of	of	ADP
iajs-2646	29	49	lipid	lipid	ADJ
iajs-2646	29	50	profiles	profile	NOUN
iajs-2646	29	51	and	and	CCONJ
iajs-2646	29	52	myocardial	myocardial	ADJ
iajs-2646	29	53	markers	marker	NOUN
iajs-2646	29	54	in	in	ADP
iajs-2646	29	55	newly	newly	ADV
iajs-2646	29	56	diagnosed	diagnose	VERB
iajs-2646	29	57	ra	ra	NOUN
iajs-2646	29	58	patients	patient	NOUN
iajs-2646	29	59	.	.	PUNCT
iajs-2646	30	1	2	2	X
iajs-2646	30	2	.	.	X
iajs-2646	30	3	materials	material	NOUN
iajs-2646	30	4	method	method	VERB
iajs-2646	30	5	seventy	seventy	NUM
iajs-2646	30	6	newly	newly	ADV
iajs-2646	30	7	diagnosed	diagnose	VERB
iajs-2646	30	8	iraqi	iraqi	ADJ
iajs-2646	30	9	patients	patient	NOUN
iajs-2646	30	10	with	with	ADP
iajs-2646	30	11	rheumatoid	rheumatoid	NOUN
iajs-2646	30	12	arthritis	arthritis	NOUN
iajs-2646	30	13	and	and	CCONJ
iajs-2646	30	14	thirty	thirty	NUM
iajs-2646	30	15	healthy	healthy	ADJ
iajs-2646	30	16	(	(	PUNCT
iajs-2646	30	17	male	male	ADJ
iajs-2646	30	18	and	and	CCONJ
iajs-2646	30	19	female	female	NOUN
iajs-2646	30	20	)	)	PUNCT
iajs-2646	30	21	are	be	AUX
iajs-2646	30	22	recruited	recruit	VERB
iajs-2646	30	23	from	from	ADP
iajs-2646	30	24	the	the	DET
iajs-2646	30	25	al	al	PROPN
iajs-2646	30	26	-	-	PUNCT
iajs-2646	30	27	husain	husain	PROPN
iajs-2646	30	28	hospital	hospital	NOUN
iajs-2646	30	29	in	in	ADP
iajs-2646	30	30	thi	thi	PROPN
iajs-2646	30	31	-	-	PUNCT
iajs-2646	30	32	qar	qar	PROPN
iajs-2646	30	33	city	city	NOUN
iajs-2646	30	34	at	at	ADP
iajs-2646	30	35	age	age	NOUN
iajs-2646	30	36	of	of	ADP
iajs-2646	30	37	35	35	NUM
iajs-2646	30	38	-	-	SYM
iajs-2646	30	39	65	65	NUM
iajs-2646	30	40	years	year	NOUN
iajs-2646	30	41	.	.	PUNCT
iajs-2646	31	1	five	five	NUM
iajs-2646	31	2	ml	ml	NOUN
iajs-2646	31	3	blood	blood	NOUN
iajs-2646	31	4	was	be	AUX
iajs-2646	31	5	collected	collect	VERB
iajs-2646	31	6	from	from	ADP
iajs-2646	31	7	the	the	DET
iajs-2646	31	8	antecubital	antecubital	ADJ
iajs-2646	31	9	vein	vein	NOUN
iajs-2646	31	10	of	of	ADP
iajs-2646	31	11	each	each	PRON
iajs-2646	31	12	of	of	ADP
iajs-2646	31	13	the	the	DET
iajs-2646	31	14	patients	patient	NOUN
iajs-2646	31	15	and	and	CCONJ
iajs-2646	31	16	healthy	healthy	ADJ
iajs-2646	31	17	and	and	CCONJ
iajs-2646	31	18	put	put	VERB
iajs-2646	31	19	in	in	ADP
iajs-2646	31	20	dry	dry	ADJ
iajs-2646	31	21	sterilized	sterilize	VERB
iajs-2646	31	22	test	test	NOUN
iajs-2646	31	23	tubes	tube	NOUN
iajs-2646	31	24	.	.	PUNCT
iajs-2646	32	1	the	the	DET
iajs-2646	32	2	blood	blood	NOUN
iajs-2646	32	3	samples	sample	NOUN
iajs-2646	32	4	were	be	AUX
iajs-2646	32	5	centrifuged	centrifuge	VERB
iajs-2646	32	6	for	for	ADP
iajs-2646	32	7	5min	5min	NOUN
iajs-2646	32	8	at	at	ADP
iajs-2646	32	9	3000rpm	3000rpm	NUM
iajs-2646	32	10	to	to	PART
iajs-2646	32	11	obtain	obtain	VERB
iajs-2646	32	12	the	the	DET
iajs-2646	32	13	serum	serum	NOUN
iajs-2646	32	14	that	that	PRON
iajs-2646	32	15	used	use	VERB
iajs-2646	32	16	to	to	PART
iajs-2646	32	17	determine	determine	VERB
iajs-2646	32	18	myocardial	myocardial	ADJ
iajs-2646	32	19	markers	marker	NOUN
iajs-2646	32	20	;	;	PUNCT
iajs-2646	32	21	included	include	VERB
iajs-2646	32	22	troponin	troponin	PROPN
iajs-2646	32	23	,	,	PUNCT
iajs-2646	32	24	ck	ck	PROPN
iajs-2646	32	25	,	,	PUNCT
iajs-2646	32	26	ldh	ldh	PROPN
iajs-2646	32	27	,	,	PUNCT
iajs-2646	32	28	and	and	CCONJ
iajs-2646	32	29	got	get	VERB
iajs-2646	32	30	;	;	PUNCT
iajs-2646	32	31	and	and	CCONJ
iajs-2646	32	32	lipid	lipid	NOUN
iajs-2646	32	33	profiles	profile	NOUN
iajs-2646	32	34	;	;	PUNCT
iajs-2646	32	35	included	include	VERB
iajs-2646	32	36	cholesterol	cholesterol	NOUN
iajs-2646	32	37	,	,	PUNCT
iajs-2646	32	38	triglyceride	triglyceride	ADJ
iajs-2646	32	39	,	,	PUNCT
iajs-2646	32	40	hdl	hdl	PROPN
iajs-2646	32	41	,	,	PUNCT
iajs-2646	32	42	ldl	ldl	NOUN
iajs-2646	32	43	,	,	PUNCT
iajs-2646	32	44	and	and	CCONJ
iajs-2646	32	45	vldl	vldl	PROPN
iajs-2646	32	46	;	;	PUNCT
iajs-2646	32	47	using	use	VERB
iajs-2646	32	48	a	a	DET
iajs-2646	32	49	kit	kit	NOUN
iajs-2646	32	50	from	from	ADP
iajs-2646	32	51	roch	roch	PROPN
iajs-2646	32	52	(	(	PUNCT
iajs-2646	32	53	germany	germany	PROPN
iajs-2646	32	54	)	)	PUNCT
iajs-2646	32	55	,	,	PUNCT
iajs-2646	32	56	measured	measure	VERB
iajs-2646	32	57	automatically	automatically	ADV
iajs-2646	32	58	with	with	ADP
iajs-2646	32	59	minividas	minividas	PROPN
iajs-2646	32	60	,	,	PUNCT
iajs-2646	32	61	biomerieux	biomerieux	PROPN
iajs-2646	32	62	(	(	PUNCT
iajs-2646	32	63	france	france	PROPN
iajs-2646	32	64	)	)	PUNCT
iajs-2646	32	65	.	.	PUNCT
iajs-2646	33	1	the	the	DET
iajs-2646	33	2	results	result	NOUN
iajs-2646	33	3	were	be	AUX
iajs-2646	33	4	computed	compute	VERB
iajs-2646	33	5	as	as	ADP
iajs-2646	33	6	the	the	DET
iajs-2646	33	7	mean	mean	PROPN
iajs-2646	33	8	±	±	NOUN
iajs-2646	33	9	standard	standard	NOUN
iajs-2646	33	10	error	error	NOUN
iajs-2646	33	11	.	.	PUNCT
iajs-2646	34	1	in	in	ADP
iajs-2646	34	2	all	all	DET
iajs-2646	34	3	statistical	statistical	ADJ
iajs-2646	34	4	analyses	analysis	NOUN
iajs-2646	34	5	,	,	PUNCT
iajs-2646	34	6	only	only	ADV
iajs-2646	34	7	p	p	ADP
iajs-2646	34	8	≤	≤	NUM
iajs-2646	34	9	0.05	0.05	NUM
iajs-2646	34	10	was	be	AUX
iajs-2646	34	11	considered	consider	VERB
iajs-2646	34	12	significant	significant	ADJ
iajs-2646	34	13	.	.	PUNCT
iajs-2646	35	1	differences	difference	NOUN
iajs-2646	35	2	among	among	ADP
iajs-2646	35	3	groups	group	NOUN
iajs-2646	35	4	were	be	AUX
iajs-2646	35	5	analyzed	analyze	VERB
iajs-2646	35	6	by	by	ADP
iajs-2646	35	7	variance	variance	NOUN
iajs-2646	35	8	oneway	oneway	NOUN
iajs-2646	35	9	analysis	analysis	NOUN
iajs-2646	35	10	anova	anova	PROPN
iajs-2646	35	11	followed	follow	VERB
iajs-2646	35	12	by	by	ADP
iajs-2646	35	13	fisher	fisher	PROPN
iajs-2646	35	14	's	's	PART
iajs-2646	35	15	test	test	NOUN
iajs-2646	35	16	for	for	ADP
iajs-2646	35	17	multiple	multiple	ADJ
iajs-2646	35	18	comparisons	comparison	NOUN
iajs-2646	35	19	,	,	PUNCT
iajs-2646	35	20	using	use	VERB
iajs-2646	35	21	statview	statview	NOUN
iajs-2646	35	22	version	version	NOUN
iajs-2646	35	23	5.0	5.0	NUM
iajs-2646	35	24	.	.	PUNCT
iajs-2646	36	1	differences	difference	NOUN
iajs-2646	36	2	were	be	AUX
iajs-2646	36	3	considered	consider	VERB
iajs-2646	36	4	significant	significant	ADJ
iajs-2646	36	5	when	when	SCONJ
iajs-2646	36	6	p<0.05	p<0.05	NOUN
iajs-2646	36	7	.	.	PUNCT
iajs-2646	37	1	regression	regression	NOUN
iajs-2646	37	2	analysis	analysis	NOUN
iajs-2646	37	3	was	be	AUX
iajs-2646	37	4	performed	perform	VERB
iajs-2646	37	5	by	by	ADP
iajs-2646	37	6	analysis	analysis	NOUN
iajs-2646	37	7	of	of	ADP
iajs-2646	37	8	covariance	covariance	NOUN
iajs-2646	37	9	(	(	PUNCT
iajs-2646	37	10	ancova	ancova	NOUN
iajs-2646	37	11	)	)	PUNCT
iajs-2646	37	12	also	also	ADV
iajs-2646	37	13	using	use	VERB
iajs-2646	37	14	stat	stat	PROPN
iajs-2646	37	15	view	view	VERB
iajs-2646	37	16	version	version	NOUN
iajs-2646	37	17	5.0	5.0	NUM
iajs-2646	37	18	.	.	PUNCT
iajs-2646	38	1	3	3	X
iajs-2646	38	2	.	.	NOUN
iajs-2646	38	3	results	result	NOUN
iajs-2646	38	4	and	and	CCONJ
iajs-2646	38	5	discussion	discussion	NOUN
iajs-2646	38	6	there	there	PRON
iajs-2646	38	7	are	be	VERB
iajs-2646	38	8	no	no	DET
iajs-2646	38	9	differences	difference	NOUN
iajs-2646	38	10	between	between	ADP
iajs-2646	38	11	levels	level	NOUN
iajs-2646	38	12	of	of	ADP
iajs-2646	38	13	myocardial	myocardial	ADJ
iajs-2646	38	14	markers	marker	NOUN
iajs-2646	38	15	in	in	ADP
iajs-2646	38	16	ra	ra	PROPN
iajs-2646	38	17	patients	patient	NOUN
iajs-2646	38	18	comparing	compare	VERB
iajs-2646	38	19	with	with	ADP
iajs-2646	38	20	the	the	DET
iajs-2646	38	21	healthy	healthy	ADJ
iajs-2646	38	22	group	group	NOUN
iajs-2646	38	23	included	include	VERB
iajs-2646	38	24	troponin	troponin	PROPN
iajs-2646	38	25	,	,	PUNCT
iajs-2646	38	26	creatinine	creatinine	PROPN
iajs-2646	38	27	kinase	kinase	PROPN
iajs-2646	38	28	,	,	PUNCT
iajs-2646	38	29	got	get	VERB
iajs-2646	38	30	,	,	PUNCT
iajs-2646	38	31	and	and	CCONJ
iajs-2646	38	32	lactate	lactate	NOUN
iajs-2646	38	33	dehydrogenase	dehydrogenase	NOUN
iajs-2646	38	34	.	.	PUNCT
iajs-2646	39	1	moreover	moreover	ADV
iajs-2646	39	2	,	,	PUNCT
iajs-2646	39	3	there	there	PRON
iajs-2646	39	4	are	be	VERB
iajs-2646	39	5	no	no	DET
iajs-2646	39	6	differences	difference	NOUN
iajs-2646	39	7	between	between	ADP
iajs-2646	39	8	these	these	DET
iajs-2646	39	9	enzyme	enzyme	NOUN
iajs-2646	39	10	levels	level	NOUN
iajs-2646	39	11	in	in	ADP
iajs-2646	39	12	male	male	ADJ
iajs-2646	39	13	and	and	CCONJ
iajs-2646	39	14	female	female	ADJ
iajs-2646	39	15	groups	group	NOUN
iajs-2646	39	16	.	.	PUNCT
iajs-2646	40	1	however	however	ADV
iajs-2646	40	2	,	,	PUNCT
iajs-2646	40	3	they	they	PRON
iajs-2646	40	4	were	be	AUX
iajs-2646	40	5	within	within	ADP
iajs-2646	40	6	normal	normal	ADJ
iajs-2646	40	7	values	value	NOUN
iajs-2646	40	8	which	which	PRON
iajs-2646	40	9	are	be	AUX
iajs-2646	40	10	as	as	ADP
iajs-2646	40	11	following	follow	VERB
iajs-2646	40	12	:	:	PUNCT
iajs-2646	40	13	(	(	PUNCT
iajs-2646	40	14	troponin=0	troponin=0	PROPN
iajs-2646	40	15	-	-	PUNCT
iajs-2646	40	16	0.4ng	0.4ng	NUM
iajs-2646	40	17	/	/	SYM
iajs-2646	40	18	ml	ml	NOUN
iajs-2646	40	19	,	,	PUNCT
iajs-2646	40	20	ck=22	ck=22	NOUN
iajs-2646	40	21	-	-	PUNCT
iajs-2646	40	22	198u	198u	PROPN
iajs-2646	40	23	/	/	SYM
iajs-2646	40	24	l	l	NOUN
iajs-2646	40	25	,	,	PUNCT
iajs-2646	40	26	got=8	got=8	NOUN
iajs-2646	40	27	-	-	PUNCT
iajs-2646	40	28	45u	45u	NOUN
iajs-2646	40	29	/	/	SYM
iajs-2646	40	30	l	l	NOUN
iajs-2646	40	31	,	,	PUNCT
iajs-2646	40	32	and	and	CCONJ
iajs-2646	40	33	ldh=140	ldh=140	PROPN
iajs-2646	40	34	-	-	PUNCT
iajs-2646	40	35	280u	280u	PROPN
iajs-2646	40	36	/	/	SYM
iajs-2646	40	37	l	l	NOUN
iajs-2646	40	38	)	)	PUNCT
iajs-2646	40	39	(	(	PUNCT
iajs-2646	40	40	figure	figure	NOUN
iajs-2646	40	41	1	1	NUM
iajs-2646	40	42	)	)	PUNCT
iajs-2646	40	43	.	.	PUNCT
iajs-2646	41	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2646	41	2	special	special	ADJ
iajs-2646	41	3	issue	issue	NOUN
iajs-2646	41	4	1220	1220	NUM
iajs-2646	41	5	icpasih	icpasih	NOUN
iajs-2646	41	6	ibn	ibn	PROPN
iajs-2646	41	7	al	al	PROPN
iajs-2646	41	8	-	-	PUNCT
iajs-2646	41	9	haitham	haitham	PROPN
iajs-2646	41	10	journal	journal	PROPN
iajs-2646	41	11	for	for	ADP
iajs-2646	41	12	pure	pure	ADJ
iajs-2646	41	13	and	and	CCONJ
iajs-2646	41	14	applied	apply	VERB
iajs-2646	41	15	science	science	NOUN
iajs-2646	41	16	https://doi.org/	https://doi.org/	NOUN
iajs-2646	41	17	10.30526/2021.ihicpas.2646	10.30526/2021.ihicpas.2646	NOUN
iajs-2646	41	18	for	for	ADP
iajs-2646	41	19	more	more	ADJ
iajs-2646	41	20	information	information	NOUN
iajs-2646	41	21	about	about	ADP
iajs-2646	41	22	the	the	DET
iajs-2646	41	23	conference	conference	NOUN
iajs-2646	41	24	please	please	INTJ
iajs-2646	41	25	visit	visit	VERB
iajs-2646	41	26	the	the	DET
iajs-2646	41	27	websites	website	NOUN
iajs-2646	41	28	:	:	PUNCT
iajs-2646	41	29	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2646	41	30	b	b	NOUN
iajs-2646	42	1	i	i	NOUN
iajs-2646	42	2	o	o	NOUN
iajs-2646	43	1	l	l	NOUN
iajs-2646	43	2	o	o	X
iajs-2646	44	1	g	g	NOUN
iajs-2646	45	1	y	y	PROPN
iajs-2646	46	1	|	|	ADV
iajs-2646	46	2	25	25	NUM
iajs-2646	46	3	figure	figure	NOUN
iajs-2646	46	4	1	1	NUM
iajs-2646	46	5	.	.	PUNCT
iajs-2646	46	6	myocardial	myocardial	ADJ
iajs-2646	46	7	markers	marker	NOUN
iajs-2646	46	8	levels	level	NOUN
iajs-2646	46	9	in	in	ADP
iajs-2646	46	10	rheumatoid	rheumatoid	NOUN
iajs-2646	46	11	arthritis	arthritis	NOUN
iajs-2646	46	12	patients	patient	NOUN
iajs-2646	46	13	and	and	CCONJ
iajs-2646	46	14	control	control	NOUN
iajs-2646	46	15	groups	group	NOUN
iajs-2646	46	16	.	.	PUNCT
iajs-2646	47	1	(	(	PUNCT
iajs-2646	47	2	a	a	X
iajs-2646	47	3	)	)	PUNCT
iajs-2646	47	4	troponin	troponin	ADJ
iajs-2646	47	5	,	,	PUNCT
iajs-2646	47	6	(	(	PUNCT
iajs-2646	47	7	b	b	X
iajs-2646	47	8	)	)	PUNCT
iajs-2646	47	9	creatinine	creatinine	NOUN
iajs-2646	47	10	kinase	kinase	NOUN
iajs-2646	47	11	(	(	PUNCT
iajs-2646	47	12	ck	ck	PROPN
iajs-2646	47	13	)	)	PUNCT
iajs-2646	47	14	,	,	PUNCT
iajs-2646	47	15	(	(	PUNCT
iajs-2646	47	16	c	c	X
iajs-2646	47	17	)	)	PUNCT
iajs-2646	47	18	glutamic	glutamic	ADJ
iajs-2646	47	19	oxaloacetic	oxaloacetic	ADJ
iajs-2646	47	20	transaminas	transamina	NOUN
iajs-2646	47	21	got	get	VERB
iajs-2646	47	22	,	,	PUNCT
iajs-2646	47	23	(	(	PUNCT
iajs-2646	47	24	d	d	X
iajs-2646	47	25	)	)	PUNCT
iajs-2646	47	26	lactate	lactate	NOUN
iajs-2646	47	27	dehydrogenase	dehydrogenase	NOUN
iajs-2646	47	28	(	(	PUNCT
iajs-2646	47	29	ldh	ldh	PROPN
iajs-2646	47	30	)	)	PUNCT
iajs-2646	47	31	.	.	PUNCT
iajs-2646	48	1	figure	figure	NOUN
iajs-2646	48	2	2	2	NUM
iajs-2646	48	3	shows	show	VERB
iajs-2646	48	4	lipid	lipid	NOUN
iajs-2646	48	5	profile	profile	NOUN
iajs-2646	48	6	levels	level	NOUN
iajs-2646	48	7	in	in	ADP
iajs-2646	48	8	both	both	DET
iajs-2646	48	9	ra	ra	PROPN
iajs-2646	48	10	patients	patient	NOUN
iajs-2646	48	11	and	and	CCONJ
iajs-2646	48	12	healthy	healthy	ADJ
iajs-2646	48	13	groups	group	NOUN
iajs-2646	48	14	(	(	PUNCT
iajs-2646	48	15	male	male	ADJ
iajs-2646	48	16	and	and	CCONJ
iajs-2646	48	17	female	female	NOUN
iajs-2646	48	18	)	)	PUNCT
iajs-2646	48	19	.	.	PUNCT
iajs-2646	49	1	there	there	PRON
iajs-2646	49	2	were	be	VERB
iajs-2646	49	3	no	no	DET
iajs-2646	49	4	differences	difference	NOUN
iajs-2646	49	5	in	in	ADP
iajs-2646	49	6	all	all	DET
iajs-2646	49	7	lipid	lipid	ADJ
iajs-2646	49	8	profiles	profile	NOUN
iajs-2646	49	9	levels	level	NOUN
iajs-2646	49	10	of	of	ADP
iajs-2646	49	11	control	control	NOUN
iajs-2646	49	12	and	and	CCONJ
iajs-2646	49	13	ra	ra	PROPN
iajs-2646	49	14	patients	patient	NOUN
iajs-2646	49	15	groups	group	NOUN
iajs-2646	49	16	however	however	ADV
iajs-2646	49	17	they	they	PRON
iajs-2646	49	18	were	be	AUX
iajs-2646	49	19	within	within	ADP
iajs-2646	49	20	normal	normal	ADJ
iajs-2646	49	21	values	value	NOUN
iajs-2646	49	22	which	which	PRON
iajs-2646	49	23	are	be	AUX
iajs-2646	49	24	as	as	ADP
iajs-2646	49	25	following	follow	VERB
iajs-2646	49	26	:	:	PUNCT
iajs-2646	49	27	(	(	PUNCT
iajs-2646	49	28	cholestrol˂150mg	cholestrol˂150mg	X
iajs-2646	49	29	/	/	SYM
iajs-2646	49	30	dl	dl	NOUN
iajs-2646	49	31	,	,	PUNCT
iajs-2646	49	32	triglyceride˂150mg	triglyceride˂150mg	ADJ
iajs-2646	49	33	/	/	SYM
iajs-2646	49	34	dl	dl	ADJ
iajs-2646	49	35	,	,	PUNCT
iajs-2646	49	36	hdl=40	hdl=40	NOUN
iajs-2646	49	37	-	-	PUNCT
iajs-2646	49	38	59mg	59mg	NOUN
iajs-2646	49	39	/	/	SYM
iajs-2646	49	40	dl	dl	PROPN
iajs-2646	49	41	,	,	PUNCT
iajs-2646	49	42	vldl=2	vldl=2	PROPN
iajs-2646	49	43	-	-	PUNCT
iajs-2646	49	44	30mg	30mg	NUM
iajs-2646	49	45	/	/	SYM
iajs-2646	49	46	dl	dl	NOUN
iajs-2646	49	47	,	,	PUNCT
iajs-2646	49	48	and	and	CCONJ
iajs-2646	49	49	ldl˂100mg	ldl˂100mg	NUM
iajs-2646	49	50	/	/	SYM
iajs-2646	49	51	dl	dl	NOUN
iajs-2646	49	52	)	)	PUNCT
iajs-2646	49	53	.	.	PUNCT
iajs-2646	50	1	moreover	moreover	ADV
iajs-2646	50	2	,	,	PUNCT
iajs-2646	50	3	there	there	PRON
iajs-2646	50	4	are	be	VERB
iajs-2646	50	5	no	no	DET
iajs-2646	50	6	differences	difference	NOUN
iajs-2646	50	7	between	between	ADP
iajs-2646	50	8	these	these	DET
iajs-2646	50	9	enzyme	enzyme	NOUN
iajs-2646	50	10	levels	level	NOUN
iajs-2646	50	11	in	in	ADP
iajs-2646	50	12	male	male	ADJ
iajs-2646	50	13	and	and	CCONJ
iajs-2646	50	14	female	female	ADJ
iajs-2646	50	15	groups	group	NOUN
iajs-2646	50	16	.	.	PUNCT
iajs-2646	51	1	interestingly	interestingly	ADV
iajs-2646	51	2	,	,	PUNCT
iajs-2646	51	3	the	the	DET
iajs-2646	51	4	cholesterol	cholesterol	NOUN
iajs-2646	51	5	/	/	SYM
iajs-2646	51	6	hdl	hdl	PROPN
iajs-2646	51	7	ratio	ratio	NOUN
iajs-2646	51	8	was	be	AUX
iajs-2646	51	9	also	also	ADV
iajs-2646	51	10	calculated	calculate	VERB
iajs-2646	51	11	.	.	PUNCT
iajs-2646	52	1	it	it	PRON
iajs-2646	52	2	increased	increase	VERB
iajs-2646	52	3	significantly	significantly	ADV
iajs-2646	52	4	from	from	ADP
iajs-2646	52	5	(	(	PUNCT
iajs-2646	52	6	2.53±0.027	2.53±0.027	NOUN
iajs-2646	52	7	)	)	PUNCT
iajs-2646	52	8	in	in	ADP
iajs-2646	52	9	control	control	NOUN
iajs-2646	52	10	to	to	ADP
iajs-2646	52	11	(	(	PUNCT
iajs-2646	52	12	3.78±0.26	3.78±0.26	PROPN
iajs-2646	52	13	)	)	PUNCT
iajs-2646	52	14	in	in	ADP
iajs-2646	52	15	ra	ra	PROPN
iajs-2646	52	16	patients	patient	NOUN
iajs-2646	52	17	.	.	PUNCT
iajs-2646	53	1	figure	figure	NOUN
iajs-2646	53	2	2	2	NUM
iajs-2646	53	3	.	.	PUNCT
iajs-2646	53	4	lipid	lipid	NOUN
iajs-2646	53	5	profiles	profile	NOUN
iajs-2646	53	6	levels	level	NOUN
iajs-2646	53	7	in	in	ADP
iajs-2646	53	8	rheumatoid	rheumatoid	NOUN
iajs-2646	53	9	arthritis	arthritis	NOUN
iajs-2646	53	10	patients	patient	NOUN
iajs-2646	53	11	and	and	CCONJ
iajs-2646	53	12	control	control	NOUN
iajs-2646	53	13	groups	group	NOUN
iajs-2646	53	14	.	.	PUNCT
iajs-2646	54	1	(	(	PUNCT
iajs-2646	54	2	a	a	X
iajs-2646	54	3	)	)	PUNCT
iajs-2646	54	4	cholestrol	cholestrol	NOUN
iajs-2646	54	5	,	,	PUNCT
iajs-2646	54	6	(	(	PUNCT
iajs-2646	54	7	b	b	NOUN
iajs-2646	54	8	)	)	PUNCT
iajs-2646	54	9	triglyceridle	triglyceridle	NOUN
iajs-2646	54	10	,	,	PUNCT
iajs-2646	54	11	(	(	PUNCT
iajs-2646	54	12	c	c	X
iajs-2646	54	13	)	)	PUNCT
iajs-2646	54	14	high	high	ADJ
iajs-2646	54	15	-	-	PUNCT
iajs-2646	54	16	density	density	NOUN
iajs-2646	54	17	lipoprotein	lipoprotein	ADJ
iajs-2646	54	18	(	(	PUNCT
iajs-2646	54	19	hdl	hdl	NOUN
iajs-2646	54	20	)	)	PUNCT
iajs-2646	54	21	,	,	PUNCT
iajs-2646	54	22	(	(	PUNCT
iajs-2646	54	23	d	d	X
iajs-2646	54	24	)	)	PUNCT
iajs-2646	54	25	very	very	ADV
iajs-2646	54	26	-	-	PUNCT
iajs-2646	54	27	low	low	ADJ
iajs-2646	54	28	-	-	PUNCT
iajs-2646	54	29	density	density	NOUN
iajs-2646	54	30	lipoprotein	lipoprotein	ADJ
iajs-2646	54	31	(	(	PUNCT
iajs-2646	54	32	vldl	vldl	NOUN
iajs-2646	54	33	)	)	PUNCT
iajs-2646	54	34	,	,	PUNCT
iajs-2646	54	35	(	(	PUNCT
iajs-2646	54	36	e	e	NOUN
iajs-2646	54	37	)	)	PUNCT
iajs-2646	54	38	low	low	ADJ
iajs-2646	54	39	-	-	PUNCT
iajs-2646	54	40	density	density	NOUN
iajs-2646	54	41	lipoprotein	lipoprotein	ADJ
iajs-2646	54	42	(	(	PUNCT
iajs-2646	54	43	ldl	ldl	NOUN
iajs-2646	54	44	)	)	PUNCT
iajs-2646	54	45	.	.	PUNCT
iajs-2646	55	1	the	the	DET
iajs-2646	55	2	correlation	correlation	NOUN
iajs-2646	55	3	between	between	ADP
iajs-2646	55	4	all	all	DET
iajs-2646	55	5	these	these	DET
iajs-2646	55	6	markers	marker	NOUN
iajs-2646	55	7	and	and	CCONJ
iajs-2646	55	8	age	age	NOUN
iajs-2646	55	9	was	be	AUX
iajs-2646	55	10	also	also	ADV
iajs-2646	55	11	calculated	calculate	VERB
iajs-2646	55	12	.	.	PUNCT
iajs-2646	56	1	there	there	PRON
iajs-2646	56	2	were	be	VERB
iajs-2646	56	3	only	only	ADV
iajs-2646	56	4	significantly	significantly	ADV
iajs-2646	56	5	positive	positive	ADJ
iajs-2646	56	6	correlations	correlation	NOUN
iajs-2646	56	7	between	between	ADP
iajs-2646	56	8	cholesterol	cholesterol	NOUN
iajs-2646	56	9	and	and	CCONJ
iajs-2646	56	10	triglyceride	triglyceride	ADJ
iajs-2646	56	11	with	with	ADP
iajs-2646	56	12	age	age	NOUN
iajs-2646	56	13	whereas	whereas	SCONJ
iajs-2646	56	14	there	there	PRON
iajs-2646	56	15	http://ihicps.com/	http://ihicps.com/	VERB
iajs-2646	56	16	special	special	ADJ
iajs-2646	56	17	issue	issue	NOUN
iajs-2646	56	18	1220	1220	NUM
iajs-2646	56	19	icpasih	icpasih	NOUN
iajs-2646	56	20	ibn	ibn	PROPN
iajs-2646	56	21	al	al	PROPN
iajs-2646	56	22	-	-	PUNCT
iajs-2646	56	23	haitham	haitham	PROPN
iajs-2646	56	24	journal	journal	PROPN
iajs-2646	56	25	for	for	ADP
iajs-2646	56	26	pure	pure	ADJ
iajs-2646	56	27	and	and	CCONJ
iajs-2646	56	28	applied	apply	VERB
iajs-2646	56	29	science	science	NOUN
iajs-2646	56	30	https://doi.org/	https://doi.org/	NOUN
iajs-2646	56	31	10.30526/2021.ihicpas.2646	10.30526/2021.ihicpas.2646	NOUN
iajs-2646	56	32	for	for	ADP
iajs-2646	56	33	more	more	ADJ
iajs-2646	56	34	information	information	NOUN
iajs-2646	56	35	about	about	ADP
iajs-2646	56	36	the	the	DET
iajs-2646	56	37	conference	conference	NOUN
iajs-2646	56	38	please	please	INTJ
iajs-2646	56	39	visit	visit	VERB
iajs-2646	56	40	the	the	DET
iajs-2646	56	41	websites	website	NOUN
iajs-2646	56	42	:	:	PUNCT
iajs-2646	56	43	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2646	56	44	b	b	NOUN
iajs-2646	57	1	i	i	NOUN
iajs-2646	57	2	o	o	NOUN
iajs-2646	58	1	l	l	NOUN
iajs-2646	58	2	o	o	X
iajs-2646	59	1	g	g	NOUN
iajs-2646	60	1	y	y	PROPN
iajs-2646	61	1	|	|	ADV
iajs-2646	61	2	26	26	NUM
iajs-2646	61	3	was	be	AUX
iajs-2646	61	4	no	no	DET
iajs-2646	61	5	correlation	correlation	NOUN
iajs-2646	61	6	between	between	ADP
iajs-2646	61	7	other	other	ADJ
iajs-2646	61	8	markers	marker	NOUN
iajs-2646	61	9	and	and	CCONJ
iajs-2646	61	10	age	age	NOUN
iajs-2646	61	11	(	(	PUNCT
iajs-2646	61	12	table	table	NOUN
iajs-2646	61	13	1	1	NUM
iajs-2646	61	14	)	)	PUNCT
iajs-2646	61	15	.	.	PUNCT
iajs-2646	62	1	table	table	NOUN
iajs-2646	62	2	1	1	NUM
iajs-2646	62	3	.	.	PUNCT
iajs-2646	63	1	the	the	DET
iajs-2646	63	2	correlation	correlation	NOUN
iajs-2646	63	3	between	between	ADP
iajs-2646	63	4	lipid	lipid	NOUN
iajs-2646	63	5	profiles	profile	NOUN
iajs-2646	63	6	and	and	CCONJ
iajs-2646	63	7	myocardial	myocardial	ADJ
iajs-2646	63	8	markers	marker	NOUN
iajs-2646	63	9	.	.	PUNCT
iajs-2646	64	1	parameters	parameter	NOUN
iajs-2646	64	2	age	age	NOUN
iajs-2646	64	3	r	r	NOUN
iajs-2646	64	4	p.	p.	NOUN
iajs-2646	64	5	value	value	NOUN
iajs-2646	64	6	myocardial	myocardial	ADJ
iajs-2646	64	7	markers	marker	NOUN
iajs-2646	64	8	troponin	troponin	ADJ
iajs-2646	64	9	0.134	0.134	NUM
iajs-2646	64	10	0.198	0.198	NUM
iajs-2646	64	11	ck	ck	NOUN
iajs-2646	64	12	0.077	0.077	NUM
iajs-2646	64	13	0.455	0.455	NUM
iajs-2646	64	14	got	get	VERB
iajs-2646	64	15	0.01	0.01	NUM
iajs-2646	64	16	0.890	0.890	NUM
iajs-2646	64	17	ldh	ldh	VERB
iajs-2646	64	18	0.122	0.122	NUM
iajs-2646	64	19	0.247	0.247	NUM
iajs-2646	64	20	lipid	lipid	NOUN
iajs-2646	64	21	profils	profils	PROPN
iajs-2646	64	22	cholestrol	cholestrol	PROPN
iajs-2646	64	23	0.219	0.219	NUM
iajs-2646	64	24	0.049	0.049	NUM
iajs-2646	64	25	triglyceride	triglyceride	ADP
iajs-2646	64	26	0.305	0.305	NUM
iajs-2646	64	27	0.002	0.002	NUM
iajs-2646	64	28	hdl	hdl	NOUN
iajs-2646	64	29	0.01	0.01	NUM
iajs-2646	64	30	0.946	0.946	NUM
iajs-2646	64	31	ldl	ldl	NOUN
iajs-2646	64	32	0.055	0.055	NUM
iajs-2646	64	33	0.687	0.687	NUM
iajs-2646	64	34	vldl	vldl	NOUN
iajs-2646	64	35	0.045	0.045	NUM
iajs-2646	64	36	0.687	0.687	NUM
iajs-2646	64	37	4	4	NUM
iajs-2646	64	38	.	.	PUNCT
iajs-2646	64	39	discussion	discussion	NOUN
iajs-2646	64	40	since	since	SCONJ
iajs-2646	64	41	ra	ra	PROPN
iajs-2646	64	42	patients	patient	NOUN
iajs-2646	64	43	have	have	VERB
iajs-2646	64	44	a	a	DET
iajs-2646	64	45	higher	high	ADJ
iajs-2646	64	46	rate	rate	NOUN
iajs-2646	64	47	of	of	ADP
iajs-2646	64	48	cardiovascular	cardiovascular	ADJ
iajs-2646	64	49	disease	disease	NOUN
iajs-2646	64	50	risk	risk	NOUN
iajs-2646	64	51	compared	compare	VERB
iajs-2646	64	52	to	to	ADP
iajs-2646	64	53	individuals	individual	NOUN
iajs-2646	64	54	without	without	ADP
iajs-2646	64	55	autoimmune	autoimmune	ADJ
iajs-2646	64	56	diseases	disease	NOUN
iajs-2646	64	57	[	[	X
iajs-2646	64	58	10	10	NUM
iajs-2646	64	59	]	]	PUNCT
iajs-2646	64	60	,	,	PUNCT
iajs-2646	64	61	periodic	periodic	ADJ
iajs-2646	64	62	examination	examination	NOUN
iajs-2646	64	63	of	of	ADP
iajs-2646	64	64	cardiovascular	cardiovascular	ADJ
iajs-2646	64	65	risk	risk	NOUN
iajs-2646	64	66	according	accord	VERB
iajs-2646	64	67	to	to	ADP
iajs-2646	64	68	the	the	DET
iajs-2646	64	69	national	national	ADJ
iajs-2646	64	70	guidelines	guideline	NOUN
iajs-2646	64	71	used	use	VERB
iajs-2646	64	72	for	for	ADP
iajs-2646	64	73	the	the	DET
iajs-2646	64	74	care	care	NOUN
iajs-2646	64	75	of	of	ADP
iajs-2646	64	76	ra	ra	PROPN
iajs-2646	64	77	patients	patient	NOUN
iajs-2646	64	78	[	[	X
iajs-2646	64	79	11	11	NUM
iajs-2646	64	80	]	]	PUNCT
iajs-2646	64	81	.	.	PUNCT
iajs-2646	65	1	however	however	ADV
iajs-2646	65	2	,	,	PUNCT
iajs-2646	65	3	the	the	DET
iajs-2646	65	4	general	general	ADJ
iajs-2646	65	5	risk	risk	NOUN
iajs-2646	65	6	calculators	calculator	NOUN
iajs-2646	65	7	used	use	VERB
iajs-2646	65	8	do	do	AUX
iajs-2646	65	9	not	not	PART
iajs-2646	65	10	succeed	succeed	VERB
iajs-2646	65	11	in	in	ADP
iajs-2646	65	12	capturing	capture	VERB
iajs-2646	65	13	the	the	DET
iajs-2646	65	14	increased	increase	VERB
iajs-2646	65	15	risks	risk	NOUN
iajs-2646	65	16	in	in	ADP
iajs-2646	65	17	these	these	DET
iajs-2646	65	18	patients	patient	NOUN
iajs-2646	65	19	[	[	X
iajs-2646	65	20	12	12	NUM
iajs-2646	65	21	,	,	PUNCT
iajs-2646	65	22	13	13	NUM
iajs-2646	65	23	]	]	PUNCT
iajs-2646	65	24	.	.	PUNCT
iajs-2646	66	1	cardiovascular	cardiovascular	ADJ
iajs-2646	66	2	disease	disease	NOUN
iajs-2646	66	3	risk	risk	NOUN
iajs-2646	66	4	is	be	AUX
iajs-2646	66	5	associated	associate	VERB
iajs-2646	66	6	with	with	ADP
iajs-2646	66	7	many	many	ADJ
iajs-2646	66	8	mechanisms	mechanism	NOUN
iajs-2646	66	9	,	,	PUNCT
iajs-2646	66	10	for	for	ADP
iajs-2646	66	11	example	example	NOUN
iajs-2646	66	12	,	,	PUNCT
iajs-2646	66	13	the	the	DET
iajs-2646	66	14	adverse	adverse	ADJ
iajs-2646	66	15	effects	effect	NOUN
iajs-2646	66	16	of	of	ADP
iajs-2646	66	17	pharmacological	pharmacological	ADJ
iajs-2646	66	18	ra	ra	PROPN
iajs-2646	66	19	,	,	PUNCT
iajs-2646	66	20	ra	ra	PROPN
iajs-2646	66	21	treatment	treatment	NOUN
iajs-2646	66	22	,	,	PUNCT
iajs-2646	66	23	and	and	CCONJ
iajs-2646	66	24	accelerated	accelerate	VERB
iajs-2646	66	25	atherosclerosis	atherosclerosis	NOUN
iajs-2646	66	26	due	due	ADP
iajs-2646	66	27	to	to	ADP
iajs-2646	66	28	inflammatory	inflammatory	ADJ
iajs-2646	66	29	processes	process	NOUN
iajs-2646	66	30	associated	associate	VERB
iajs-2646	66	31	with	with	ADP
iajs-2646	66	32	long	long	ADJ
iajs-2646	66	33	-	-	PUNCT
iajs-2646	66	34	term	term	NOUN
iajs-2646	66	35	ra	ra	PROPN
iajs-2646	67	1	[	[	X
iajs-2646	67	2	14	14	NUM
iajs-2646	67	3	-	-	SYM
iajs-2646	67	4	17	17	NUM
iajs-2646	67	5	]	]	PUNCT
iajs-2646	67	6	.	.	PUNCT
iajs-2646	68	1	in	in	ADP
iajs-2646	68	2	our	our	PRON
iajs-2646	68	3	work	work	NOUN
iajs-2646	68	4	,	,	PUNCT
iajs-2646	68	5	all	all	DET
iajs-2646	68	6	patients	patient	NOUN
iajs-2646	68	7	were	be	AUX
iajs-2646	68	8	newly	newly	ADV
iajs-2646	68	9	diagnosed	diagnose	VERB
iajs-2646	68	10	with	with	ADP
iajs-2646	68	11	rheumatoid	rheumatoid	NOUN
iajs-2646	68	12	arthritis	arthritis	NOUN
iajs-2646	68	13	,	,	PUNCT
iajs-2646	68	14	so	so	SCONJ
iajs-2646	68	15	this	this	PRON
iajs-2646	68	16	could	could	AUX
iajs-2646	68	17	be	be	AUX
iajs-2646	68	18	the	the	DET
iajs-2646	68	19	reason	reason	NOUN
iajs-2646	68	20	why	why	SCONJ
iajs-2646	68	21	there	there	PRON
iajs-2646	68	22	was	be	VERB
iajs-2646	68	23	n’t	not	PART
iajs-2646	68	24	a	a	DET
iajs-2646	68	25	difference	difference	NOUN
iajs-2646	68	26	between	between	ADP
iajs-2646	68	27	cardiac	cardiac	ADJ
iajs-2646	68	28	parameters	parameter	NOUN
iajs-2646	68	29	levels	level	NOUN
iajs-2646	68	30	in	in	ADP
iajs-2646	68	31	ra	ra	PROPN
iajs-2646	68	32	patients	patient	NOUN
iajs-2646	68	33	compared	compare	VERB
iajs-2646	68	34	with	with	ADP
iajs-2646	68	35	healthy	healthy	ADJ
iajs-2646	68	36	groups	group	NOUN
iajs-2646	68	37	.	.	PUNCT
iajs-2646	69	1	kremers	kremer	NOUN
iajs-2646	69	2	et	et	PROPN
iajs-2646	69	3	al	al	PROPN
iajs-2646	69	4	and	and	CCONJ
iajs-2646	69	5	lindhardsen	lindhardsen	PROPN
iajs-2646	69	6	et	et	PROPN
iajs-2646	69	7	al	al	PROPN
iajs-2646	69	8	also	also	ADV
iajs-2646	69	9	stated	state	VERB
iajs-2646	69	10	that	that	SCONJ
iajs-2646	69	11	the	the	DET
iajs-2646	69	12	cardiovascular	cardiovascular	ADJ
iajs-2646	69	13	disease	disease	NOUN
iajs-2646	69	14	risk	risk	NOUN
iajs-2646	69	15	in	in	ADP
iajs-2646	69	16	ra	ra	PROPN
iajs-2646	69	17	patients	patient	NOUN
iajs-2646	69	18	was	be	AUX
iajs-2646	69	19	similar	similar	ADJ
iajs-2646	69	20	to	to	ADP
iajs-2646	69	21	that	that	PRON
iajs-2646	69	22	of	of	ADP
iajs-2646	69	23	people	people	NOUN
iajs-2646	69	24	without	without	ADP
iajs-2646	69	25	rheumatoid	rheumatoid	NOUN
iajs-2646	69	26	arthritis	arthritis	NOUN
iajs-2646	69	27	[	[	X
iajs-2646	69	28	7	7	NUM
iajs-2646	69	29	,	,	PUNCT
iajs-2646	69	30	18	18	NUM
iajs-2646	69	31	]	]	PUNCT
iajs-2646	69	32	.	.	PUNCT
iajs-2646	70	1	but	but	CCONJ
iajs-2646	70	2	this	this	DET
iajs-2646	70	3	result	result	NOUN
iajs-2646	70	4	does	do	AUX
iajs-2646	70	5	not	not	PART
iajs-2646	70	6	exclude	exclude	VERB
iajs-2646	70	7	the	the	DET
iajs-2646	70	8	possibility	possibility	NOUN
iajs-2646	70	9	of	of	ADP
iajs-2646	70	10	an	an	DET
iajs-2646	70	11	increase	increase	NOUN
iajs-2646	70	12	in	in	ADP
iajs-2646	70	13	cardiovascular	cardiovascular	ADJ
iajs-2646	70	14	disease	disease	NOUN
iajs-2646	70	15	risk	risk	NOUN
iajs-2646	70	16	after	after	ADP
iajs-2646	70	17	5–10	5–10	ADJ
iajs-2646	70	18	years	year	NOUN
iajs-2646	70	19	of	of	ADP
iajs-2646	70	20	rheumatoid	rheumatoid	NOUN
iajs-2646	70	21	arthritis	arthritis	NOUN
iajs-2646	70	22	,	,	PUNCT
iajs-2646	70	23	although	although	SCONJ
iajs-2646	70	24	intensive	intensive	ADJ
iajs-2646	70	25	treatment	treatment	NOUN
iajs-2646	70	26	aimed	aim	VERB
iajs-2646	70	27	at	at	ADP
iajs-2646	70	28	controlling	control	VERB
iajs-2646	70	29	inflammation	inflammation	NOUN
iajs-2646	70	30	in	in	ADP
iajs-2646	70	31	recent	recent	ADJ
iajs-2646	70	32	years	year	NOUN
iajs-2646	70	33	is	be	AUX
iajs-2646	70	34	likely	likely	ADJ
iajs-2646	70	35	to	to	PART
iajs-2646	70	36	decrease	decrease	VERB
iajs-2646	70	37	the	the	DET
iajs-2646	70	38	cardiovascular	cardiovascular	ADJ
iajs-2646	70	39	disease	disease	NOUN
iajs-2646	70	40	risk	risk	NOUN
iajs-2646	70	41	rate	rate	NOUN
iajs-2646	70	42	that	that	PRON
iajs-2646	70	43	increases	increase	VERB
iajs-2646	70	44	during	during	ADP
iajs-2646	70	45	the	the	DET
iajs-2646	70	46	period	period	NOUN
iajs-2646	70	47	of	of	ADP
iajs-2646	70	48	rheumatoid	rheumatoid	NOUN
iajs-2646	70	49	arthritis	arthritis	NOUN
iajs-2646	70	50	[	[	X
iajs-2646	70	51	19	19	NUM
iajs-2646	70	52	]	]	PUNCT
iajs-2646	70	53	.	.	PUNCT
iajs-2646	71	1	it	it	PRON
iajs-2646	71	2	is	be	AUX
iajs-2646	71	3	known	know	VERB
iajs-2646	71	4	that	that	SCONJ
iajs-2646	71	5	the	the	DET
iajs-2646	71	6	lipid	lipid	NOUN
iajs-2646	71	7	profile	profile	NOUN
iajs-2646	71	8	is	be	AUX
iajs-2646	71	9	one	one	NUM
iajs-2646	71	10	of	of	ADP
iajs-2646	71	11	the	the	DET
iajs-2646	71	12	signs	sign	NOUN
iajs-2646	71	13	of	of	ADP
iajs-2646	71	14	cardiovascular	cardiovascular	ADJ
iajs-2646	71	15	disease	disease	NOUN
iajs-2646	71	16	because	because	SCONJ
iajs-2646	71	17	it	it	PRON
iajs-2646	71	18	makes	make	VERB
iajs-2646	71	19	rheumatoid	rheumatoid	VERB
iajs-2646	71	20	arthritis	arthritis	NOUN
iajs-2646	71	21	patients	patient	NOUN
iajs-2646	71	22	triple	triple	ADJ
iajs-2646	71	23	cardiovascular	cardiovascular	ADJ
iajs-2646	71	24	disease	disease	NOUN
iajs-2646	71	25	risk	risk	NOUN
iajs-2646	71	26	.	.	PUNCT
iajs-2646	72	1	after	after	ADV
iajs-2646	72	2	all	all	ADV
iajs-2646	72	3	,	,	PUNCT
iajs-2646	72	4	this	this	DET
iajs-2646	72	5	disease	disease	NOUN
iajs-2646	72	6	itself	itself	PRON
iajs-2646	72	7	caused	cause	VERB
iajs-2646	72	8	atherosclerosis	atherosclerosis	NOUN
iajs-2646	72	9	(	(	PUNCT
iajs-2646	72	10	1	1	NUM
iajs-2646	72	11	)	)	PUNCT
iajs-2646	72	12	.	.	PUNCT
iajs-2646	73	1	lipid	lipid	PROPN
iajs-2646	73	2	levels	level	NOUN
iajs-2646	73	3	seem	seem	VERB
iajs-2646	73	4	to	to	PART
iajs-2646	73	5	change	change	VERB
iajs-2646	73	6	due	due	ADJ
iajs-2646	73	7	to	to	PART
iajs-2646	73	8	rheumatoid	rheumatoid	VERB
iajs-2646	73	9	arthritis	arthritis	NOUN
iajs-2646	73	10	activity	activity	NOUN
iajs-2646	73	11	.	.	PUNCT
iajs-2646	74	1	data	datum	NOUN
iajs-2646	74	2	of	of	ADP
iajs-2646	74	3	total	total	ADJ
iajs-2646	74	4	cholesterol	cholesterol	NOUN
iajs-2646	74	5	and	and	CCONJ
iajs-2646	74	6	low	low	ADJ
iajs-2646	74	7	-	-	PUNCT
iajs-2646	74	8	density	density	NOUN
iajs-2646	74	9	cholesterol	cholesterol	NOUN
iajs-2646	74	10	concentrations	concentration	NOUN
iajs-2646	74	11	differ	differ	VERB
iajs-2646	74	12	in	in	ADP
iajs-2646	74	13	ra	ra	PROPN
iajs-2646	74	14	patients	patient	NOUN
iajs-2646	74	15	.	.	PUNCT
iajs-2646	75	1	some	some	DET
iajs-2646	75	2	works	work	NOUN
iajs-2646	75	3	show	show	VERB
iajs-2646	75	4	similar	similar	ADJ
iajs-2646	75	5	levels	level	NOUN
iajs-2646	75	6	[	[	X
iajs-2646	75	7	20	20	NUM
iajs-2646	75	8	]	]	PUNCT
iajs-2646	75	9	or	or	CCONJ
iajs-2646	75	10	less	less	ADJ
iajs-2646	75	11	[	[	X
iajs-2646	75	12	21	21	NUM
iajs-2646	75	13	]	]	PUNCT
iajs-2646	75	14	of	of	ADP
iajs-2646	75	15	total	total	ADJ
iajs-2646	75	16	cholesterol	cholesterol	NOUN
iajs-2646	75	17	,	,	PUNCT
iajs-2646	75	18	however	however	ADV
iajs-2646	75	19	other	other	ADJ
iajs-2646	75	20	researches	research	NOUN
iajs-2646	75	21	indicated	indicate	VERB
iajs-2646	75	22	high	high	ADJ
iajs-2646	75	23	concentration	concentration	NOUN
iajs-2646	75	24	of	of	ADP
iajs-2646	75	25	total	total	ADJ
iajs-2646	75	26	cholesterol	cholesterol	NOUN
iajs-2646	75	27	and	and	CCONJ
iajs-2646	75	28	ldl	ldl	VERB
iajs-2646	75	29	cholesterol	cholesterol	NOUN
iajs-2646	75	30	in	in	ADP
iajs-2646	75	31	early	early	ADJ
iajs-2646	75	32	ra	ra	PROPN
iajs-2646	75	33	patients	patient	NOUN
iajs-2646	75	34	[	[	X
iajs-2646	75	35	22	22	NUM
iajs-2646	75	36	]	]	PUNCT
iajs-2646	75	37	or	or	CCONJ
iajs-2646	75	38	indicate	indicate	VERB
iajs-2646	75	39	decreased	decrease	VERB
iajs-2646	75	40	total	total	ADJ
iajs-2646	75	41	cholesterol	cholesterol	NOUN
iajs-2646	75	42	,	,	PUNCT
iajs-2646	75	43	ldl	ldl	NOUN
iajs-2646	75	44	,	,	PUNCT
iajs-2646	75	45	and	and	CCONJ
iajs-2646	75	46	hdl	hdl	PROPN
iajs-2646	75	47	inactive	inactive	PROPN
iajs-2646	75	48	untreated	untreated	ADJ
iajs-2646	75	49	ra	ra	PROPN
iajs-2646	75	50	patients	patient	NOUN
iajs-2646	75	51	[	[	X
iajs-2646	75	52	6	6	NUM
iajs-2646	75	53	,	,	PUNCT
iajs-2646	75	54	21	21	NUM
iajs-2646	75	55	,	,	PUNCT
iajs-2646	75	56	23	23	NUM
iajs-2646	75	57	]	]	PUNCT
iajs-2646	75	58	.	.	PUNCT
iajs-2646	76	1	in	in	ADP
iajs-2646	76	2	our	our	PRON
iajs-2646	76	3	results	result	NOUN
iajs-2646	76	4	,	,	PUNCT
iajs-2646	76	5	there	there	PRON
iajs-2646	76	6	was	be	VERB
iajs-2646	76	7	no	no	DET
iajs-2646	76	8	difference	difference	NOUN
iajs-2646	76	9	in	in	ADP
iajs-2646	76	10	all	all	DET
iajs-2646	76	11	lipid	lipid	ADJ
iajs-2646	76	12	profiles	profile	NOUN
iajs-2646	76	13	between	between	ADP
iajs-2646	76	14	ra	ra	PROPN
iajs-2646	76	15	patients	patient	NOUN
iajs-2646	76	16	and	and	CCONJ
iajs-2646	76	17	the	the	DET
iajs-2646	76	18	health	health	NOUN
iajs-2646	76	19	group	group	NOUN
iajs-2646	76	20	.	.	PUNCT
iajs-2646	77	1	regardless	regardless	ADV
iajs-2646	77	2	of	of	ADP
iajs-2646	77	3	the	the	DET
iajs-2646	77	4	changes	change	NOUN
iajs-2646	77	5	in	in	ADP
iajs-2646	77	6	total	total	ADJ
iajs-2646	77	7	cholesterol	cholesterol	NOUN
iajs-2646	77	8	and	and	CCONJ
iajs-2646	77	9	hdl	hdl	PROPN
iajs-2646	77	10	in	in	ADP
iajs-2646	77	11	ra	ra	PROPN
iajs-2646	77	12	patients	patient	NOUN
iajs-2646	77	13	,	,	PUNCT
iajs-2646	77	14	several	several	ADJ
iajs-2646	77	15	studies	study	NOUN
iajs-2646	77	16	support	support	VERB
iajs-2646	77	17	the	the	DET
iajs-2646	77	18	calculating	calculate	VERB
iajs-2646	77	19	importance	importance	NOUN
iajs-2646	77	20	of	of	ADP
iajs-2646	77	21	total	total	ADJ
iajs-2646	77	22	cholesterol	cholesterol	NOUN
iajs-2646	77	23	to	to	ADP
iajs-2646	77	24	hdl	hdl	PROPN
iajs-2646	77	25	ratio	ratio	PROPN
iajs-2646	77	26	in	in	ADP
iajs-2646	77	27	ra	ra	PROPN
iajs-2646	77	28	patients	patient	NOUN
iajs-2646	77	29	,	,	PUNCT
iajs-2646	77	30	which	which	PRON
iajs-2646	77	31	leads	lead	VERB
iajs-2646	77	32	to	to	ADP
iajs-2646	77	33	a	a	DET
iajs-2646	77	34	more	more	ADV
iajs-2646	77	35	fatty	fatty	NOUN
iajs-2646	77	36	arteriosclerosis	arteriosclerosis	NOUN
iajs-2646	77	37	profile	profile	NOUN
iajs-2646	77	38	and	and	CCONJ
iajs-2646	77	39	is	be	AUX
iajs-2646	77	40	associated	associate	VERB
iajs-2646	77	41	with	with	ADP
iajs-2646	77	42	disease	disease	NOUN
iajs-2646	77	43	activity	activity	NOUN
iajs-2646	77	44	and	and	CCONJ
iajs-2646	77	45	http://ihicps.com/	http://ihicps.com/	VERB
iajs-2646	77	46	special	special	ADJ
iajs-2646	77	47	issue	issue	NOUN
iajs-2646	77	48	1220	1220	NUM
iajs-2646	77	49	icpasih	icpasih	NOUN
iajs-2646	77	50	ibn	ibn	PROPN
iajs-2646	77	51	al	al	PROPN
iajs-2646	77	52	-	-	PUNCT
iajs-2646	77	53	haitham	haitham	PROPN
iajs-2646	77	54	journal	journal	PROPN
iajs-2646	77	55	for	for	ADP
iajs-2646	77	56	pure	pure	ADJ
iajs-2646	77	57	and	and	CCONJ
iajs-2646	77	58	applied	apply	VERB
iajs-2646	77	59	science	science	NOUN
iajs-2646	77	60	https://doi.org/	https://doi.org/	NOUN
iajs-2646	77	61	10.30526/2021.ihicpas.2646	10.30526/2021.ihicpas.2646	NOUN
iajs-2646	77	62	for	for	ADP
iajs-2646	77	63	more	more	ADJ
iajs-2646	77	64	information	information	NOUN
iajs-2646	77	65	about	about	ADP
iajs-2646	77	66	the	the	DET
iajs-2646	77	67	conference	conference	NOUN
iajs-2646	77	68	please	please	INTJ
iajs-2646	77	69	visit	visit	VERB
iajs-2646	77	70	the	the	DET
iajs-2646	77	71	websites	website	NOUN
iajs-2646	77	72	:	:	PUNCT
iajs-2646	77	73	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2646	77	74	b	b	NOUN
iajs-2646	78	1	i	i	NOUN
iajs-2646	78	2	o	o	NOUN
iajs-2646	79	1	l	l	NOUN
iajs-2646	79	2	o	o	X
iajs-2646	80	1	g	g	NOUN
iajs-2646	80	2	y	y	PROPN
iajs-2646	80	3	|	|	ADV
iajs-2646	80	4	27	27	NUM
iajs-2646	80	5	improves	improve	VERB
iajs-2646	80	6	after	after	ADP
iajs-2646	80	7	treatment	treatment	NOUN
iajs-2646	80	8	with	with	ADP
iajs-2646	80	9	antirheumatic	antirheumatic	ADJ
iajs-2646	80	10	drugs	drug	NOUN
iajs-2646	80	11	[	[	X
iajs-2646	80	12	20	20	NUM
iajs-2646	80	13	,	,	PUNCT
iajs-2646	80	14	21	21	NUM
iajs-2646	80	15	,	,	PUNCT
iajs-2646	80	16	22	22	NUM
iajs-2646	80	17	,	,	PUNCT
iajs-2646	80	18	24	24	NUM
iajs-2646	80	19	]	]	PUNCT
iajs-2646	80	20	.	.	PUNCT
iajs-2646	81	1	in	in	ADP
iajs-2646	81	2	our	our	PRON
iajs-2646	81	3	results	result	NOUN
iajs-2646	81	4	,	,	PUNCT
iajs-2646	81	5	the	the	DET
iajs-2646	81	6	cholesterol	cholesterol	PROPN
iajs-2646	81	7	/	/	SYM
iajs-2646	81	8	hdl	hdl	PROPN
iajs-2646	81	9	ratio	ratio	PROPN
iajs-2646	81	10	increased	increase	VERB
iajs-2646	81	11	significantly	significantly	ADV
iajs-2646	81	12	in	in	ADP
iajs-2646	81	13	the	the	DET
iajs-2646	81	14	ra	ra	PROPN
iajs-2646	81	15	patients	patient	NOUN
iajs-2646	81	16	than	than	ADP
iajs-2646	81	17	in	in	ADP
iajs-2646	81	18	the	the	DET
iajs-2646	81	19	control	control	NOUN
iajs-2646	81	20	group	group	NOUN
iajs-2646	81	21	.	.	PUNCT
iajs-2646	82	1	a	a	DET
iajs-2646	82	2	similar	similar	ADJ
iajs-2646	82	3	gender	gender	NOUN
iajs-2646	82	4	-	-	PUNCT
iajs-2646	82	5	based	base	VERB
iajs-2646	82	6	pattern	pattern	NOUN
iajs-2646	82	7	of	of	ADP
iajs-2646	82	8	cardiovascular	cardiovascular	ADJ
iajs-2646	82	9	disease	disease	NOUN
iajs-2646	82	10	risk	risk	NOUN
iajs-2646	82	11	observed	observe	VERB
iajs-2646	82	12	in	in	ADP
iajs-2646	82	13	this	this	DET
iajs-2646	82	14	study	study	NOUN
iajs-2646	82	15	was	be	AUX
iajs-2646	82	16	reported	report	VERB
iajs-2646	82	17	by	by	ADP
iajs-2646	82	18	[	[	X
iajs-2646	82	19	25	25	NUM
iajs-2646	82	20	]	]	PUNCT
iajs-2646	82	21	and	and	CCONJ
iajs-2646	82	22	[	[	X
iajs-2646	82	23	7	7	NUM
iajs-2646	82	24	]	]	PUNCT
iajs-2646	82	25	,	,	PUNCT
iajs-2646	82	26	who	who	PRON
iajs-2646	82	27	also	also	ADV
iajs-2646	82	28	found	find	VERB
iajs-2646	82	29	no	no	DET
iajs-2646	82	30	general	general	ADJ
iajs-2646	82	31	difference	difference	NOUN
iajs-2646	82	32	in	in	ADP
iajs-2646	82	33	cardiovascular	cardiovascular	ADJ
iajs-2646	82	34	disease	disease	NOUN
iajs-2646	82	35	risk	risk	NOUN
iajs-2646	82	36	between	between	ADP
iajs-2646	82	37	genders	gender	NOUN
iajs-2646	82	38	whereas	whereas	SCONJ
iajs-2646	82	39	there	there	PRON
iajs-2646	82	40	were	be	VERB
iajs-2646	82	41	n’t	not	PART
iajs-2646	82	42	differences	difference	NOUN
iajs-2646	82	43	in	in	ADP
iajs-2646	82	44	lipid	lipid	NOUN
iajs-2646	82	45	profile	profile	NOUN
iajs-2646	82	46	and	and	CCONJ
iajs-2646	82	47	myocardial	myocardial	ADJ
iajs-2646	82	48	markers	marker	NOUN
iajs-2646	82	49	between	between	ADP
iajs-2646	82	50	women	woman	NOUN
iajs-2646	82	51	and	and	CCONJ
iajs-2646	82	52	men	man	NOUN
iajs-2646	82	53	with	with	ADP
iajs-2646	82	54	ra	ra	PROPN
iajs-2646	82	55	in	in	ADP
iajs-2646	82	56	this	this	DET
iajs-2646	82	57	study	study	NOUN
iajs-2646	82	58	.	.	PUNCT
iajs-2646	83	1	4	4	X
iajs-2646	83	2	.	.	X
iajs-2646	83	3	conclusion	conclusion	NOUN
iajs-2646	83	4	in	in	ADP
iajs-2646	83	5	conclusion	conclusion	NOUN
iajs-2646	83	6	,	,	PUNCT
iajs-2646	83	7	the	the	DET
iajs-2646	83	8	cardiovascular	cardiovascular	ADJ
iajs-2646	83	9	disease	disease	NOUN
iajs-2646	83	10	risk	risk	NOUN
iajs-2646	83	11	could	could	AUX
iajs-2646	83	12	be	be	AUX
iajs-2646	83	13	increase	increase	VERB
iajs-2646	83	14	also	also	ADV
iajs-2646	83	15	in	in	ADP
iajs-2646	83	16	the	the	DET
iajs-2646	83	17	patient	patient	NOUN
iajs-2646	83	18	with	with	ADP
iajs-2646	83	19	newly	newly	ADV
iajs-2646	83	20	diagnostic	diagnostic	ADJ
iajs-2646	83	21	rheumatoid	rheumatoid	NOUN
iajs-2646	83	22	arthritis	arthritis	NOUN
iajs-2646	83	23	so	so	SCONJ
iajs-2646	83	24	other	other	ADJ
iajs-2646	83	25	patient	patient	ADJ
iajs-2646	83	26	characteristics	characteristic	NOUN
iajs-2646	83	27	,	,	PUNCT
iajs-2646	83	28	such	such	ADJ
iajs-2646	83	29	as	as	ADP
iajs-2646	83	30	gender	gender	NOUN
iajs-2646	83	31	,	,	PUNCT
iajs-2646	83	32	age	age	NOUN
iajs-2646	83	33	at	at	ADP
iajs-2646	83	34	the	the	DET
iajs-2646	83	35	onset	onset	NOUN
iajs-2646	83	36	of	of	ADP
iajs-2646	83	37	the	the	DET
iajs-2646	83	38	disease	disease	NOUN
iajs-2646	83	39	,	,	PUNCT
iajs-2646	83	40	disease	disease	NOUN
iajs-2646	83	41	severity	severity	NOUN
iajs-2646	83	42	markers	marker	NOUN
iajs-2646	83	43	,	,	PUNCT
iajs-2646	83	44	and	and	CCONJ
iajs-2646	83	45	tc	tc	X
iajs-2646	83	46	/	/	SYM
iajs-2646	83	47	hdl	hdl	PROPN
iajs-2646	83	48	ratio	ratio	NOUN
iajs-2646	83	49	should	should	AUX
iajs-2646	83	50	be	be	AUX
iajs-2646	83	51	probably	probably	ADV
iajs-2646	83	52	included	include	VERB
iajs-2646	83	53	in	in	ADP
iajs-2646	83	54	a	a	DET
iajs-2646	83	55	model	model	NOUN
iajs-2646	83	56	to	to	PART
iajs-2646	83	57	predict	predict	VERB
iajs-2646	83	58	the	the	DET
iajs-2646	83	59	cardiovascular	cardiovascular	ADJ
iajs-2646	83	60	disease	disease	NOUN
iajs-2646	83	61	risk	risk	NOUN
iajs-2646	83	62	for	for	ADP
iajs-2646	83	63	ra	ra	PROPN
iajs-2646	83	64	,	,	PUNCT
iajs-2646	83	65	developing	develop	VERB
iajs-2646	83	66	such	such	DET
iajs-2646	83	67	a	a	DET
iajs-2646	83	68	model	model	NOUN
iajs-2646	83	69	,	,	PUNCT
iajs-2646	83	70	validating	validate	VERB
iajs-2646	83	71	it	it	PRON
iajs-2646	83	72	and	and	CCONJ
iajs-2646	83	73	assessing	assess	VERB
iajs-2646	83	74	its	its	PRON
iajs-2646	83	75	primary	primary	ADJ
iajs-2646	83	76	and	and	CCONJ
iajs-2646	83	77	secondary	secondary	ADJ
iajs-2646	83	78	prevention	prevention	NOUN
iajs-2646	83	79	strategies	strategy	NOUN
iajs-2646	83	80	for	for	ADP
iajs-2646	83	81	cardiovascular	cardiovascular	ADJ
iajs-2646	83	82	disease	disease	NOUN
iajs-2646	83	83	in	in	ADP
iajs-2646	83	84	rheumatoid	rheumatoid	NOUN
iajs-2646	83	85	arthritis	arthritis	NOUN
iajs-2646	83	86	patients	patient	NOUN
iajs-2646	83	87	.	.	PUNCT
iajs-2646	84	1	references	reference	NOUN
iajs-2646	84	2	1	1	NUM
iajs-2646	84	3	.	.	X
iajs-2646	85	1	erum	erum	PROPN
iajs-2646	85	2	,	,	PUNCT
iajs-2646	85	3	u.	u.	PROPN
iajs-2646	85	4	;	;	PUNCT
iajs-2646	85	5	ahsan	ahsan	PROPN
iajs-2646	85	6	,	,	PUNCT
iajs-2646	85	7	t	t	PROPN
iajs-2646	85	8	;	;	PUNCT
iajs-2646	85	9	khowaja	khowaja	PROPN
iajs-2646	85	10	,	,	PUNCT
iajs-2646	85	11	d.	d.	PROPN
iajs-2646	85	12	lipid	lipid	PROPN
iajs-2646	85	13	abnormalities	abnormality	NOUN
iajs-2646	85	14	in	in	ADP
iajs-2646	85	15	patients	patient	NOUN
iajs-2646	85	16	with	with	ADP
iajs-2646	85	17	rheumatoid	rheumatoid	NOUN
iajs-2646	85	18	arthritis	arthritis	NOUN
iajs-2646	85	19	.	.	PUNCT
iajs-2646	86	1	pak	pak	PROPN
iajs-2646	86	2	.	.	PUNCT
iajs-2646	87	1	j.	j.	PROPN
iajs-2646	87	2	med	med	PROPN
iajs-2646	87	3	.	.	PUNCT
iajs-2646	88	1	sci	sci	PROPN
iajs-2646	88	2	.	.	PROPN
iajs-2646	88	3	2017	2017	NUM
iajs-2646	88	4	,	,	PUNCT
iajs-2646	88	5	33	33	NUM
iajs-2646	88	6	,	,	PUNCT
iajs-2646	88	7	1	1	NUM
iajs-2646	88	8	,	,	PUNCT
iajs-2646	88	9	227	227	NUM
iajs-2646	88	10	-	-	SYM
iajs-2646	88	11	230	230	NUM
iajs-2646	88	12	.	.	PUNCT
iajs-2646	88	13	2	2	NUM
iajs-2646	88	14	.	.	X
iajs-2646	88	15	avina	avina	PROPN
iajs-2646	88	16	-	-	PUNCT
iajs-2646	88	17	zubieta	zubieta	PROPN
iajs-2646	88	18	,	,	PUNCT
iajs-2646	88	19	j.a	j.a	PROPN
iajs-2646	88	20	.	.	PROPN
iajs-2646	88	21	;	;	PUNCT
iajs-2646	88	22	thomas	thomas	PROPN
iajs-2646	88	23	,	,	PUNCT
iajs-2646	88	24	j.	j.	PROPN
iajs-2646	88	25	;	;	PUNCT
iajs-2646	88	26	sadatsafavi	sadatsafavi	ADJ
iajs-2646	88	27	,	,	PUNCT
iajs-2646	88	28	m.	m.	NOUN
iajs-2646	88	29	;	;	PUNCT
iajs-2646	88	30	lehman	lehman	PROPN
iajs-2646	88	31	,	,	PUNCT
iajs-2646	88	32	a.j	a.j	PROPN
iajs-2646	88	33	.	.	PROPN
iajs-2646	88	34	;	;	PUNCT
iajs-2646	88	35	lacaille	lacaille	NOUN
iajs-2646	88	36	,	,	PUNCT
iajs-2646	88	37	d.	d.	PROPN
iajs-2646	88	38	risk	risk	NOUN
iajs-2646	88	39	of	of	ADP
iajs-2646	88	40	incident	incident	NOUN
iajs-2646	88	41	cardiovascular	cardiovascular	ADJ
iajs-2646	88	42	events	event	NOUN
iajs-2646	88	43	in	in	ADP
iajs-2646	88	44	patients	patient	NOUN
iajs-2646	88	45	with	with	ADP
iajs-2646	88	46	rheumatoid	rheumatoid	NOUN
iajs-2646	88	47	arthritis	arthritis	NOUN
iajs-2646	88	48	:	:	PUNCT
iajs-2646	88	49	a	a	DET
iajs-2646	88	50	meta	meta	ADJ
iajs-2646	88	51	-	-	PUNCT
iajs-2646	88	52	analysis	analysis	NOUN
iajs-2646	88	53	of	of	ADP
iajs-2646	88	54	observational	observational	ADJ
iajs-2646	88	55	studies	study	NOUN
iajs-2646	88	56	.	.	PUNCT
iajs-2646	89	1	ann	ann	PROPN
iajs-2646	89	2	.	.	PUNCT
iajs-2646	89	3	rheum	rheum	PROPN
iajs-2646	89	4	.	.	PUNCT
iajs-2646	90	1	dis	dis	PROPN
iajs-2646	90	2	.	.	PUNCT
iajs-2646	91	1	2012	2012	NUM
iajs-2646	91	2	,	,	PUNCT
iajs-2646	91	3	71	71	NUM
iajs-2646	91	4	,	,	PUNCT
iajs-2646	91	5	9	9	NUM
iajs-2646	91	6	,	,	PUNCT
iajs-2646	91	7	1524	1524	NUM
iajs-2646	91	8	-	-	SYM
iajs-2646	91	9	1529	1529	NUM
iajs-2646	91	10	.	.	PUNCT
iajs-2646	92	1	3	3	X
iajs-2646	92	2	.	.	X
iajs-2646	92	3	pant	pant	NOUN
iajs-2646	92	4	,	,	PUNCT
iajs-2646	92	5	s.	s.	PROPN
iajs-2646	92	6	;	;	PUNCT
iajs-2646	92	7	deshmukh	deshmukh	PROPN
iajs-2646	92	8	,	,	PUNCT
iajs-2646	92	9	a.	a.	NOUN
iajs-2646	92	10	;	;	PUNCT
iajs-2646	92	11	neupane	neupane	ADJ
iajs-2646	92	12	,	,	PUNCT
iajs-2646	92	13	p.	p.	PROPN
iajs-2646	92	14	;	;	PUNCT
iajs-2646	92	15	kumar	kumar	PROPN
iajs-2646	92	16	,	,	PUNCT
iajs-2646	92	17	m.p.k	m.p.k	PROPN
iajs-2646	92	18	.	.	PUNCT
iajs-2646	92	19	;	;	PUNCT
iajs-2646	92	20	vijayashankar	vijayashankar	PROPN
iajs-2646	92	21	,	,	PUNCT
iajs-2646	92	22	c.s	c.s	PROPN
iajs-2646	92	23	.	.	PROPN
iajs-2646	92	24	cardiac	cardiac	ADJ
iajs-2646	92	25	biomarkers	biomarker	NOUN
iajs-2646	92	26	.	.	PUNCT
iajs-2646	93	1	in	in	ADP
iajs-2646	93	2	:	:	PUNCT
iajs-2646	93	3	lakshmandoss	lakshmandoss	PROPN
iajs-2646	93	4	u	u	PROPN
iajs-2646	93	5	,	,	PUNCT
iajs-2646	93	6	editor	editor	NOUN
iajs-2646	93	7	.	.	PUNCT
iajs-2646	94	1	noval	noval	ADJ
iajs-2646	94	2	strategies	strategy	NOUN
iajs-2646	94	3	in	in	ADP
iajs-2646	94	4	ischemic	ischemic	ADJ
iajs-2646	94	5	heart	heart	NOUN
iajs-2646	94	6	disease	disease	NOUN
iajs-2646	94	7	.	.	PUNCT
iajs-2646	95	1	india	india	PROPN
iajs-2646	95	2	:	:	PUNCT
iajs-2646	95	3	mercy	mercy	NOUN
iajs-2646	95	4	health	health	PROPN
iajs-2646	95	5	2012	2012	NUM
iajs-2646	95	6	,	,	PUNCT
iajs-2646	95	7	17	17	NUM
iajs-2646	95	8	-	-	SYM
iajs-2646	95	9	42	42	NUM
iajs-2646	95	10	.	.	PUNCT
iajs-2646	96	1	4	4	X
iajs-2646	96	2	.	.	X
iajs-2646	96	3	gabriel	gabriel	PROPN
iajs-2646	96	4	,	,	PUNCT
iajs-2646	96	5	s.e	s.e	PROPN
iajs-2646	96	6	.	.	PROPN
iajs-2646	96	7	;	;	PUNCT
iajs-2646	96	8	crowson	crowson	PROPN
iajs-2646	96	9	,	,	PUNCT
iajs-2646	96	10	c.s	c.s	PROPN
iajs-2646	96	11	.	.	PROPN
iajs-2646	96	12	risk	risk	NOUN
iajs-2646	96	13	factors	factor	NOUN
iajs-2646	96	14	for	for	ADP
iajs-2646	96	15	cardiovascular	cardiovascular	ADJ
iajs-2646	96	16	disease	disease	NOUN
iajs-2646	96	17	in	in	ADP
iajs-2646	96	18	rheumatoid	rheumatoid	NOUN
iajs-2646	96	19	arthritis	arthritis	NOUN
iajs-2646	96	20	.	.	PUNCT
iajs-2646	97	1	curr	curr	PROPN
iajs-2646	97	2	.	.	PUNCT
iajs-2646	98	1	opin	opin	NOUN
iajs-2646	98	2	.	.	PUNCT
iajs-2646	99	1	rheumatol	rheumatol	NOUN
iajs-2646	99	2	.	.	PUNCT
iajs-2646	100	1	2012	2012	NUM
iajs-2646	100	2	,	,	PUNCT
iajs-2646	100	3	24	24	NUM
iajs-2646	100	4	,	,	PUNCT
iajs-2646	100	5	2	2	NUM
iajs-2646	100	6	,	,	PUNCT
iajs-2646	100	7	171	171	NUM
iajs-2646	100	8	-	-	SYM
iajs-2646	100	9	176	176	NUM
iajs-2646	100	10	.	.	PUNCT
iajs-2646	101	1	5	5	NUM
iajs-2646	101	2	.	.	X
iajs-2646	101	3	boyer	boyer	PROPN
iajs-2646	101	4	,	,	PUNCT
iajs-2646	101	5	j.f	j.f	PROPN
iajs-2646	101	6	.	.	PROPN
iajs-2646	101	7	;	;	PUNCT
iajs-2646	101	8	gourraud	gourraud	INTJ
iajs-2646	101	9	,	,	PUNCT
iajs-2646	101	10	p.a	p.a	PROPN
iajs-2646	101	11	.	.	PUNCT
iajs-2646	101	12	;	;	PUNCT
iajs-2646	102	1	cantagrel	cantagrel	PROPN
iajs-2646	102	2	,	,	PUNCT
iajs-2646	102	3	a.	a.	NOUN
iajs-2646	102	4	;	;	PUNCT
iajs-2646	102	5	davignon	davignon	PROPN
iajs-2646	102	6	,	,	PUNCT
iajs-2646	102	7	j.l	j.l	PROPN
iajs-2646	102	8	.	.	PROPN
iajs-2646	102	9	;	;	PUNCT
iajs-2646	102	10	constantin	constantin	PROPN
iajs-2646	102	11	,	,	PUNCT
iajs-2646	102	12	a.	a.	NOUN
iajs-2646	102	13	traditional	traditional	ADJ
iajs-2646	102	14	cardiovascular	cardiovascular	ADJ
iajs-2646	102	15	risk	risk	NOUN
iajs-2646	102	16	factors	factor	NOUN
iajs-2646	102	17	in	in	ADP
iajs-2646	102	18	rheumatoid	rheumatoid	NOUN
iajs-2646	102	19	arthritis	arthritis	NOUN
iajs-2646	102	20	:	:	PUNCT
iajs-2646	102	21	a	a	DET
iajs-2646	102	22	meta	meta	ADJ
iajs-2646	102	23	-	-	PUNCT
iajs-2646	102	24	analysis	analysis	NOUN
iajs-2646	102	25	.	.	PUNCT
iajs-2646	103	1	joint	joint	ADJ
iajs-2646	103	2	bone	bone	NOUN
iajs-2646	103	3	spine	spine	NOUN
iajs-2646	103	4	.	.	PUNCT
iajs-2646	104	1	2011	2011	NUM
iajs-2646	104	2	78	78	NUM
iajs-2646	104	3	,	,	PUNCT
iajs-2646	104	4	2	2	NUM
iajs-2646	104	5	,	,	PUNCT
iajs-2646	104	6	179	179	NUM
iajs-2646	104	7	-	-	SYM
iajs-2646	104	8	183	183	NUM
iajs-2646	104	9	.	.	NOUN
iajs-2646	105	1	6	6	NUM
iajs-2646	105	2	.	.	X
iajs-2646	105	3	choy	choy	NOUN
iajs-2646	105	4	,	,	PUNCT
iajs-2646	105	5	e.	e.	PROPN
iajs-2646	105	6	;	;	PUNCT
iajs-2646	105	7	sattar	sattar	PROPN
iajs-2646	105	8	,	,	PUNCT
iajs-2646	105	9	n.	n.	NOUN
iajs-2646	105	10	interpreting	interpret	VERB
iajs-2646	105	11	lipid	lipid	NOUN
iajs-2646	105	12	levels	level	NOUN
iajs-2646	105	13	in	in	ADP
iajs-2646	105	14	the	the	DET
iajs-2646	105	15	context	context	NOUN
iajs-2646	105	16	of	of	ADP
iajs-2646	105	17	high	high	ADJ
iajs-2646	105	18	-	-	PUNCT
iajs-2646	105	19	grade	grade	NOUN
iajs-2646	105	20	inflammatory	inflammatory	ADJ
iajs-2646	105	21	states	state	NOUN
iajs-2646	105	22	with	with	ADP
iajs-2646	105	23	a	a	DET
iajs-2646	105	24	focus	focus	NOUN
iajs-2646	105	25	on	on	ADP
iajs-2646	105	26	rheumatoid	rheumatoid	NOUN
iajs-2646	105	27	arthritis	arthritis	NOUN
iajs-2646	105	28	:	:	PUNCT
iajs-2646	105	29	a	a	DET
iajs-2646	105	30	challenge	challenge	NOUN
iajs-2646	105	31	to	to	ADP
iajs-2646	105	32	conventional	conventional	ADJ
iajs-2646	105	33	cardiovascular	cardiovascular	ADJ
iajs-2646	105	34	risk	risk	NOUN
iajs-2646	105	35	actions	action	NOUN
iajs-2646	105	36	.	.	PUNCT
iajs-2646	106	1	ann	ann	PROPN
iajs-2646	106	2	.	.	PUNCT
iajs-2646	106	3	rheum	rheum	PROPN
iajs-2646	106	4	.	.	PUNCT
iajs-2646	107	1	dis	dis	PROPN
iajs-2646	107	2	.	.	PUNCT
iajs-2646	107	3	2009	2009	NUM
iajs-2646	107	4	,	,	PUNCT
iajs-2646	107	5	68	68	NUM
iajs-2646	107	6	,	,	PUNCT
iajs-2646	107	7	4	4	NUM
iajs-2646	107	8	,	,	PUNCT
iajs-2646	107	9	460	460	NUM
iajs-2646	107	10	-	-	SYM
iajs-2646	107	11	469	469	NUM
iajs-2646	107	12	.	.	NOUN
iajs-2646	107	13	7	7	NUM
iajs-2646	107	14	.	.	NUM
iajs-2646	107	15	lindhardsen	lindhardsen	PROPN
iajs-2646	107	16	,	,	PUNCT
iajs-2646	107	17	j.	j.	PROPN
iajs-2646	107	18	;	;	PUNCT
iajs-2646	107	19	ahlehoff	ahlehoff	PROPN
iajs-2646	107	20	,	,	PUNCT
iajs-2646	107	21	o.	o.	PROPN
iajs-2646	107	22	;	;	PUNCT
iajs-2646	107	23	gislason	gislason	NOUN
iajs-2646	107	24	,	,	PUNCT
iajs-2646	107	25	g.h	g.h	PROPN
iajs-2646	107	26	.	.	PROPN
iajs-2646	107	27	;	;	PUNCT
iajs-2646	107	28	madsen	madsen	PROPN
iajs-2646	107	29	,	,	PUNCT
iajs-2646	107	30	o.r	o.r	PROPN
iajs-2646	107	31	.	.	PROPN
iajs-2646	107	32	;	;	PUNCT
iajs-2646	107	33	olesen	olesen	ADJ
iajs-2646	107	34	,	,	PUNCT
iajs-2646	107	35	j.b	j.b	PROPN
iajs-2646	107	36	.	.	PROPN
iajs-2646	107	37	;	;	PUNCT
iajs-2646	107	38	torppedersen	torppedersen	NOUN
iajs-2646	107	39	.	.	PUNCT
iajs-2646	108	1	c.	c.	NOUN
iajs-2646	109	1	the	the	DET
iajs-2646	109	2	risk	risk	NOUN
iajs-2646	109	3	of	of	ADP
iajs-2646	109	4	myocardial	myocardial	ADJ
iajs-2646	109	5	infarction	infarction	NOUN
iajs-2646	109	6	in	in	ADP
iajs-2646	109	7	rheumatoid	rheumatoid	NOUN
iajs-2646	109	8	arthritis	arthritis	NOUN
iajs-2646	109	9	and	and	CCONJ
iajs-2646	109	10	diabetes	diabetes	NOUN
iajs-2646	109	11	mellitus	mellitus	NOUN
iajs-2646	109	12	:	:	PUNCT
iajs-2646	109	13	a	a	DET
iajs-2646	109	14	danish	danish	ADJ
iajs-2646	109	15	nationwide	nationwide	ADJ
iajs-2646	109	16	cohort	cohort	NOUN
iajs-2646	109	17	study	study	NOUN
iajs-2646	109	18	.	.	PUNCT
iajs-2646	110	1	ann	ann	PROPN
iajs-2646	110	2	.	.	PUNCT
iajs-2646	110	3	rheum	rheum	PROPN
iajs-2646	110	4	.	.	PUNCT
iajs-2646	111	1	dis	dis	PROPN
iajs-2646	111	2	.	.	PUNCT
iajs-2646	112	1	2011	2011	NUM
iajs-2646	112	2	,	,	PUNCT
iajs-2646	112	3	70	70	NUM
iajs-2646	112	4	,	,	PUNCT
iajs-2646	112	5	6	6	NUM
iajs-2646	112	6	,	,	PUNCT
iajs-2646	112	7	929	929	NUM
iajs-2646	112	8	-	-	SYM
iajs-2646	112	9	934	934	NUM
iajs-2646	112	10	.	.	NOUN
iajs-2646	113	1	8	8	NUM
iajs-2646	113	2	.	.	PUNCT
iajs-2646	113	3	steiner	steiner	PROPN
iajs-2646	113	4	,	,	PUNCT
iajs-2646	113	5	g.	g.	PROPN
iajs-2646	113	6	;	;	PUNCT
iajs-2646	113	7	urowitz	urowitz	PROPN
iajs-2646	113	8	.	.	PUNCT
iajs-2646	114	1	m.b	m.b	PROPN
iajs-2646	114	2	.	.	PROPN
iajs-2646	114	3	lipid	lipid	NOUN
iajs-2646	114	4	profiles	profile	NOUN
iajs-2646	114	5	in	in	ADP
iajs-2646	114	6	patients	patient	NOUN
iajs-2646	114	7	with	with	ADP
iajs-2646	114	8	rheumatoid	rheumatoid	NOUN
iajs-2646	114	9	arthritis	arthritis	NOUN
iajs-2646	114	10	:	:	PUNCT
iajs-2646	114	11	mechanisms	mechanism	NOUN
iajs-2646	114	12	and	and	CCONJ
iajs-2646	114	13	the	the	DET
iajs-2646	114	14	impact	impact	NOUN
iajs-2646	114	15	of	of	ADP
iajs-2646	114	16	treatment	treatment	NOUN
iajs-2646	114	17	.	.	PUNCT
iajs-2646	115	1	semin	semin	PROPN
iajs-2646	115	2	arthritis	arthritis	PROPN
iajs-2646	115	3	rheum	rheum	PROPN
iajs-2646	115	4	.	.	PUNCT
iajs-2646	116	1	2009	2009	NUM
iajs-2646	116	2	,	,	PUNCT
iajs-2646	116	3	38	38	NUM
iajs-2646	116	4	,	,	PUNCT
iajs-2646	116	5	5	5	NUM
iajs-2646	116	6	,	,	PUNCT
iajs-2646	116	7	372	372	NUM
iajs-2646	116	8	-	-	SYM
iajs-2646	116	9	381	381	NUM
iajs-2646	116	10	.	.	NOUN
iajs-2646	117	1	9	9	NUM
iajs-2646	117	2	.	.	X
iajs-2646	117	3	amezaga	amezaga	NOUN
iajs-2646	117	4	-	-	PUNCT
iajs-2646	117	5	urruela	urruela	PROPN
iajs-2646	117	6	,	,	PUNCT
iajs-2646	117	7	m.	m.	NOUN
iajs-2646	117	8	;	;	PUNCT
iajs-2646	117	9	suarez	suarez	PROPN
iajs-2646	117	10	-	-	PUNCT
iajs-2646	117	11	almazor	almazor	PROPN
iajs-2646	117	12	,	,	PUNCT
iajs-2646	117	13	m.e	m.e	PROPN
iajs-2646	117	14	.	.	PROPN
iajs-2646	117	15	lipid	lipid	PROPN
iajs-2646	117	16	paradox	paradox	NOUN
iajs-2646	117	17	in	in	ADP
iajs-2646	117	18	rheumatoid	rheumatoid	NOUN
iajs-2646	117	19	arthritis	arthritis	NOUN
iajs-2646	117	20	:	:	PUNCT
iajs-2646	117	21	changes	change	NOUN
iajs-2646	117	22	with	with	ADP
iajs-2646	117	23	rheumatoid	rheumatoid	NOUN
iajs-2646	117	24	arthritis	arthritis	NOUN
iajs-2646	117	25	therapies	therapy	NOUN
iajs-2646	117	26	.	.	PUNCT
iajs-2646	118	1	curr	curr	PROPN
iajs-2646	118	2	rheumatol	rheumatol	PROPN
iajs-2646	118	3	rep	rep	PROPN
iajs-2646	118	4	.	.	PROPN
iajs-2646	118	5	2012	2012	NUM
iajs-2646	118	6	,	,	PUNCT
iajs-2646	118	7	14	14	NUM
iajs-2646	118	8	,	,	PUNCT
iajs-2646	118	9	5	5	NUM
iajs-2646	118	10	,	,	PUNCT
iajs-2646	118	11	428	428	NUM
iajs-2646	118	12	-	-	SYM
iajs-2646	118	13	437	437	NUM
iajs-2646	118	14	.	.	PUNCT
iajs-2646	119	1	10	10	NUM
iajs-2646	119	2	.	.	X
iajs-2646	120	1	naranjo	naranjo	PROPN
iajs-2646	120	2	,	,	PUNCT
iajs-2646	120	3	a.	a.	NOUN
iajs-2646	120	4	;	;	PUNCT
iajs-2646	120	5	sokka	sokka	PROPN
iajs-2646	120	6	,	,	PUNCT
iajs-2646	120	7	t.	t.	PROPN
iajs-2646	120	8	;	;	PUNCT
iajs-2646	120	9	descalzo	descalzo	PROPN
iajs-2646	120	10	,	,	PUNCT
iajs-2646	120	11	m.a	m.a	PROPN
iajs-2646	120	12	.	.	PROPN
iajs-2646	120	13	;	;	PUNCT
iajs-2646	120	14	calvo	calvo	NOUN
iajs-2646	120	15	-	-	PUNCT
iajs-2646	120	16	alen	alen	PROPN
iajs-2646	120	17	,	,	PUNCT
iajs-2646	120	18	j.	j.	PROPN
iajs-2646	120	19	;	;	PUNCT
iajs-2646	120	20	horslev	horslev	ADJ
iajs-2646	120	21	-	-	PUNCT
iajs-2646	120	22	petersen	petersen	PROPN
iajs-2646	120	23	,	,	PUNCT
iajs-2646	120	24	k.	k.	PROPN
iajs-2646	120	25	;	;	PUNCT
iajs-2646	120	26	luukkainen	luukkainen	PROPN
iajs-2646	120	27	.	.	PUNCT
iajs-2646	121	1	r.k	r.k	NOUN
iajs-2646	121	2	.	.	PROPN
iajs-2646	121	3	cardiovascular	cardiovascular	ADJ
iajs-2646	121	4	disease	disease	NOUN
iajs-2646	121	5	in	in	ADP
iajs-2646	121	6	patients	patient	NOUN
iajs-2646	121	7	with	with	ADP
iajs-2646	121	8	rheumatoid	rheumatoid	NOUN
iajs-2646	121	9	arthritis	arthritis	NOUN
iajs-2646	121	10	:	:	PUNCT
iajs-2646	121	11	results	result	NOUN
iajs-2646	121	12	from	from	ADP
iajs-2646	121	13	the	the	DET
iajs-2646	121	14	quest	quest	NOUN
iajs-2646	121	15	-	-	PUNCT
iajs-2646	121	16	ra	ra	NOUN
iajs-2646	121	17	study	study	NOUN
iajs-2646	121	18	.	.	PUNCT
iajs-2646	122	1	arthritis	arthritis	NOUN
iajs-2646	122	2	res	re	NOUN
iajs-2646	122	3	.	.	PUNCT
iajs-2646	123	1	ther	ther	PROPN
iajs-2646	123	2	.	.	PUNCT
iajs-2646	124	1	2008	2008	NUM
iajs-2646	124	2	,	,	PUNCT
iajs-2646	124	3	10	10	NUM
iajs-2646	124	4	,	,	PUNCT
iajs-2646	124	5	2	2	NUM
iajs-2646	124	6	,	,	PUNCT
iajs-2646	124	7	r30	r30	NOUN
iajs-2646	124	8	.	.	PUNCT
iajs-2646	125	1	11	11	NUM
iajs-2646	125	2	.	.	PUNCT
iajs-2646	126	1	agca	agca	PROPN
iajs-2646	126	2	,	,	PUNCT
iajs-2646	126	3	r.	r.	PROPN
iajs-2646	126	4	;	;	PUNCT
iajs-2646	126	5	heslinga	heslinga	PROPN
iajs-2646	126	6	,	,	PUNCT
iajs-2646	126	7	s.c	s.c	PROPN
iajs-2646	126	8	.	.	PROPN
iajs-2646	126	9	;	;	PUNCT
iajs-2646	126	10	rollefstad	rollefstad	PROPN
iajs-2646	126	11	,	,	PUNCT
iajs-2646	126	12	s.	s.	PROPN
iajs-2646	126	13	;	;	PUNCT
iajs-2646	126	14	heslinga	heslinga	PROPN
iajs-2646	126	15	,	,	PUNCT
iajs-2646	126	16	m.	m.	NOUN
iajs-2646	126	17	;	;	PUNCT
iajs-2646	126	18	mcinnes	mcinnes	PROPN
iajs-2646	126	19	,	,	PUNCT
iajs-2646	126	20	i.b	i.b	PROPN
iajs-2646	126	21	.	.	PROPN
iajs-2646	126	22	;	;	PUNCT
iajs-2646	126	23	peters	peters	PROPN
iajs-2646	126	24	,	,	PUNCT
iajs-2646	126	25	m.j	m.j	PROPN
iajs-2646	126	26	.	.	PROPN
iajs-2646	126	27	eular	eular	ADJ
iajs-2646	126	28	recommendations	recommendation	NOUN
iajs-2646	126	29	for	for	ADP
iajs-2646	126	30	cardiovascular	cardiovascular	ADJ
iajs-2646	126	31	disease	disease	NOUN
iajs-2646	126	32	risk	risk	NOUN
iajs-2646	126	33	management	management	NOUN
iajs-2646	126	34	in	in	ADP
iajs-2646	126	35	patients	patient	NOUN
iajs-2646	126	36	with	with	ADP
iajs-2646	126	37	rheumatoid	rheumatoid	NOUN
iajs-2646	126	38	arthritis	arthritis	NOUN
iajs-2646	126	39	and	and	CCONJ
iajs-2646	126	40	other	other	ADJ
iajs-2646	126	41	forms	form	NOUN
iajs-2646	126	42	of	of	ADP
iajs-2646	126	43	inflammatory	inflammatory	ADJ
iajs-2646	126	44	joint	joint	ADJ
iajs-2646	126	45	disorders	disorder	NOUN
iajs-2646	126	46	:	:	PUNCT
iajs-2646	126	47	2015/2016	2015/2016	NUM
iajs-2646	126	48	update	update	NOUN
iajs-2646	126	49	.	.	PUNCT
iajs-2646	127	1	ann	ann	PROPN
iajs-2646	127	2	rheum	rheum	PROPN
iajs-2646	127	3	dis	dis	PROPN
iajs-2646	127	4	.	.	PROPN
iajs-2646	128	1	2017	2017	NUM
iajs-2646	128	2	,	,	PUNCT
iajs-2646	128	3	76	76	NUM
iajs-2646	128	4	,	,	PUNCT
iajs-2646	128	5	1	1	NUM
iajs-2646	128	6	,	,	PUNCT
iajs-2646	128	7	17	17	NUM
iajs-2646	128	8	-	-	SYM
iajs-2646	128	9	28	28	NUM
iajs-2646	128	10	.	.	PUNCT
iajs-2646	129	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2646	129	2	special	special	ADJ
iajs-2646	129	3	issue	issue	NOUN
iajs-2646	129	4	1220	1220	NUM
iajs-2646	129	5	icpasih	icpasih	NOUN
iajs-2646	129	6	ibn	ibn	PROPN
iajs-2646	129	7	al	al	PROPN
iajs-2646	129	8	-	-	PUNCT
iajs-2646	129	9	haitham	haitham	PROPN
iajs-2646	129	10	journal	journal	PROPN
iajs-2646	129	11	for	for	ADP
iajs-2646	129	12	pure	pure	ADJ
iajs-2646	129	13	and	and	CCONJ
iajs-2646	129	14	applied	apply	VERB
iajs-2646	129	15	science	science	NOUN
iajs-2646	129	16	https://doi.org/	https://doi.org/	NOUN
iajs-2646	129	17	10.30526/2021.ihicpas.2646	10.30526/2021.ihicpas.2646	NOUN
iajs-2646	129	18	for	for	ADP
iajs-2646	129	19	more	more	ADJ
iajs-2646	129	20	information	information	NOUN
iajs-2646	129	21	about	about	ADP
iajs-2646	129	22	the	the	DET
iajs-2646	129	23	conference	conference	NOUN
iajs-2646	129	24	please	please	INTJ
iajs-2646	129	25	visit	visit	VERB
iajs-2646	129	26	the	the	DET
iajs-2646	129	27	websites	website	NOUN
iajs-2646	129	28	:	:	PUNCT
iajs-2646	129	29	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2646	129	30	b	b	NOUN
iajs-2646	130	1	i	i	NOUN
iajs-2646	130	2	o	o	NOUN
iajs-2646	131	1	l	l	NOUN
iajs-2646	131	2	o	o	X
iajs-2646	131	3	g	g	NOUN
iajs-2646	132	1	y	y	PROPN
iajs-2646	133	1	|	|	ADV
iajs-2646	133	2	28	28	NUM
iajs-2646	133	3	12	12	NUM
iajs-2646	133	4	.	.	PUNCT
iajs-2646	134	1	crowson	crowson	PROPN
iajs-2646	134	2	,	,	PUNCT
iajs-2646	134	3	c.s	c.s	PROPN
iajs-2646	134	4	.	.	PROPN
iajs-2646	134	5	;	;	PUNCT
iajs-2646	134	6	matteson	matteson	PROPN
iajs-2646	134	7	,	,	PUNCT
iajs-2646	134	8	e.l	e.l	PROPN
iajs-2646	134	9	.	.	PROPN
iajs-2646	134	10	;	;	PUNCT
iajs-2646	134	11	roger	roger	PROPN
iajs-2646	134	12	,	,	PUNCT
iajs-2646	134	13	v.l	v.l	PROPN
iajs-2646	134	14	.	.	PROPN
iajs-2646	134	15	;	;	PUNCT
iajs-2646	134	16	therneau	therneau	PROPN
iajs-2646	134	17	,	,	PUNCT
iajs-2646	134	18	t.m	t.m	PROPN
iajs-2646	134	19	.	.	PROPN
iajs-2646	134	20	;	;	PUNCT
iajs-2646	134	21	gabriel	gabriel	PROPN
iajs-2646	134	22	,	,	PUNCT
iajs-2646	134	23	se	se	PROPN
iajs-2646	134	24	.	.	PUNCT
iajs-2646	135	1	usefulness	usefulness	NOUN
iajs-2646	135	2	of	of	ADP
iajs-2646	135	3	risk	risk	NOUN
iajs-2646	135	4	scores	score	NOUN
iajs-2646	135	5	to	to	PART
iajs-2646	135	6	estimate	estimate	VERB
iajs-2646	135	7	the	the	DET
iajs-2646	135	8	risk	risk	NOUN
iajs-2646	135	9	of	of	ADP
iajs-2646	135	10	cardiovascular	cardiovascular	ADJ
iajs-2646	135	11	disease	disease	NOUN
iajs-2646	135	12	in	in	ADP
iajs-2646	135	13	patients	patient	NOUN
iajs-2646	135	14	with	with	ADP
iajs-2646	135	15	rheumatoid	rheumatoid	NOUN
iajs-2646	135	16	arthritis	arthritis	NOUN
iajs-2646	135	17	.	.	PUNCT
iajs-2646	136	1	am	be	AUX
iajs-2646	136	2	j	j	PROPN
iajs-2646	136	3	cardiol	cardiol	NOUN
iajs-2646	136	4	.	.	PUNCT
iajs-2646	137	1	2012	2012	NUM
iajs-2646	137	2	,	,	PUNCT
iajs-2646	137	3	110	110	NUM
iajs-2646	137	4	,	,	PUNCT
iajs-2646	137	5	3	3	NUM
iajs-2646	137	6	,	,	PUNCT
iajs-2646	137	7	420	420	NUM
iajs-2646	137	8	-	-	SYM
iajs-2646	137	9	424	424	NUM
iajs-2646	137	10	.	.	NOUN
iajs-2646	138	1	13	13	NUM
iajs-2646	138	2	.	.	PUNCT
iajs-2646	139	1	siontis	siontis	PROPN
iajs-2646	139	2	,	,	PUNCT
iajs-2646	139	3	g.c	g.c	PROPN
iajs-2646	139	4	.	.	PROPN
iajs-2646	139	5	;	;	PUNCT
iajs-2646	139	6	tzoulaki	tzoulaki	PROPN
iajs-2646	139	7	,	,	PUNCT
iajs-2646	139	8	i.	i.	PROPN
iajs-2646	139	9	;	;	PUNCT
iajs-2646	139	10	siontis	siontis	PROPN
iajs-2646	139	11	,	,	PUNCT
iajs-2646	139	12	k.c	k.c	PROPN
iajs-2646	139	13	.	.	PROPN
iajs-2646	139	14	;	;	PUNCT
iajs-2646	139	15	ioannidis	ioannidis	PROPN
iajs-2646	139	16	,	,	PUNCT
iajs-2646	139	17	j.p	j.p	PROPN
iajs-2646	139	18	.	.	PROPN
iajs-2646	139	19	comparisons	comparison	NOUN
iajs-2646	139	20	of	of	ADP
iajs-2646	139	21	established	establish	VERB
iajs-2646	139	22	risk	risk	NOUN
iajs-2646	139	23	prediction	prediction	NOUN
iajs-2646	139	24	models	model	NOUN
iajs-2646	139	25	for	for	ADP
iajs-2646	139	26	cardiovascular	cardiovascular	ADJ
iajs-2646	139	27	disease	disease	NOUN
iajs-2646	139	28	:	:	PUNCT
iajs-2646	139	29	systematic	systematic	ADJ
iajs-2646	139	30	review	review	NOUN
iajs-2646	139	31	.	.	PUNCT
iajs-2646	140	1	bmj	bmj	PROPN
iajs-2646	140	2	.	.	PUNCT
iajs-2646	140	3	2012	2012	NUM
iajs-2646	140	4	,	,	PUNCT
iajs-2646	140	5	344	344	NUM
iajs-2646	140	6	,	,	PUNCT
iajs-2646	140	7	e3318	e3318	NOUN
iajs-2646	140	8	.	.	PUNCT
iajs-2646	141	1	14	14	NUM
iajs-2646	141	2	.	.	PUNCT
iajs-2646	142	1	gonzalez	gonzalez	PROPN
iajs-2646	142	2	,	,	PUNCT
iajs-2646	142	3	a.	a.	NOUN
iajs-2646	142	4	;	;	PUNCT
iajs-2646	142	5	maradit	maradit	NOUN
iajs-2646	142	6	-	-	PUNCT
iajs-2646	142	7	kremers	kremer	NOUN
iajs-2646	142	8	.	.	PUNCT
iajs-2646	143	1	h.	h.	PROPN
iajs-2646	143	2	;	;	PUNCT
iajs-2646	143	3	crowson	crowson	PROPN
iajs-2646	143	4	.	.	PUNCT
iajs-2646	144	1	c.s	c.s	PROPN
iajs-2646	144	2	.	.	PROPN
iajs-2646	144	3	;	;	PUNCT
iajs-2646	144	4	ballman	ballman	PROPN
iajs-2646	144	5	.	.	PUNCT
iajs-2646	145	1	k.v	k.v	PROPN
iajs-2646	145	2	.	.	PROPN
iajs-2646	145	3	;	;	PUNCT
iajs-2646	146	1	roger	roger	PROPN
iajs-2646	146	2	.	.	PUNCT
iajs-2646	147	1	v.l	v.l	PROPN
iajs-2646	147	2	.	.	PROPN
iajs-2646	147	3	;	;	PUNCT
iajs-2646	147	4	jacobsen	jacobsen	PROPN
iajs-2646	147	5	,	,	PUNCT
iajs-2646	147	6	s.j	s.j	PROPN
iajs-2646	147	7	.	.	PROPN
iajs-2646	147	8	do	do	AUX
iajs-2646	147	9	cardiovascular	cardiovascular	ADJ
iajs-2646	147	10	risk	risk	NOUN
iajs-2646	147	11	factors	factor	NOUN
iajs-2646	147	12	confer	confer	VERB
iajs-2646	147	13	the	the	DET
iajs-2646	147	14	same	same	ADJ
iajs-2646	147	15	risk	risk	NOUN
iajs-2646	147	16	for	for	ADP
iajs-2646	147	17	cardiovascular	cardiovascular	ADJ
iajs-2646	147	18	outcomes	outcome	NOUN
iajs-2646	147	19	in	in	ADP
iajs-2646	147	20	rheumatoid	rheumatoid	VERB
iajs-2646	147	21	arthritis	arthritis	NOUN
iajs-2646	147	22	patients	patient	NOUN
iajs-2646	147	23	as	as	ADP
iajs-2646	147	24	in	in	ADP
iajs-2646	147	25	non	non	ADJ
iajs-2646	147	26	-	-	ADJ
iajs-2646	147	27	rheumatoid	rheumatoid	ADJ
iajs-2646	147	28	arthritis	arthritis	NOUN
iajs-2646	147	29	patients	patient	NOUN
iajs-2646	147	30	?	?	PUNCT
iajs-2646	148	1	ann	ann	PROPN
iajs-2646	148	2	rheum	rheum	PROPN
iajs-2646	148	3	dis	dis	PROPN
iajs-2646	148	4	.	.	PROPN
iajs-2646	148	5	2008	2008	NUM
iajs-2646	148	6	,	,	PUNCT
iajs-2646	148	7	67	67	NUM
iajs-2646	148	8	,	,	PUNCT
iajs-2646	148	9	1	1	NUM
iajs-2646	148	10	,	,	PUNCT
iajs-2646	148	11	64	64	NUM
iajs-2646	148	12	-	-	SYM
iajs-2646	148	13	69	69	NUM
iajs-2646	148	14	.	.	PUNCT
iajs-2646	149	1	15	15	NUM
iajs-2646	149	2	.	.	PUNCT
iajs-2646	150	1	solomon	solomon	PROPN
iajs-2646	150	2	,	,	PUNCT
iajs-2646	150	3	d.h	d.h	PROPN
iajs-2646	150	4	.	.	PROPN
iajs-2646	150	5	;	;	PUNCT
iajs-2646	150	6	curhan	curhan	PROPN
iajs-2646	150	7	,	,	PUNCT
iajs-2646	150	8	g.c	g.c	PROPN
iajs-2646	150	9	.	.	PROPN
iajs-2646	150	10	;	;	PUNCT
iajs-2646	150	11	rimm	rimm	PROPN
iajs-2646	150	12	,	,	PUNCT
iajs-2646	150	13	e.b	e.b	PROPN
iajs-2646	150	14	.	.	PROPN
iajs-2646	150	15	;	;	PUNCT
iajs-2646	150	16	cannuscio	cannuscio	PROPN
iajs-2646	150	17	,	,	PUNCT
iajs-2646	150	18	c.c	c.c	PROPN
iajs-2646	150	19	.	.	PROPN
iajs-2646	150	20	;	;	PUNCT
iajs-2646	150	21	karlson	karlson	PROPN
iajs-2646	150	22	,	,	PUNCT
iajs-2646	150	23	e.w	e.w	PROPN
iajs-2646	150	24	.	.	NOUN
iajs-2646	150	25	cardiovascular	cardiovascular	ADJ
iajs-2646	150	26	risk	risk	NOUN
iajs-2646	150	27	factors	factor	NOUN
iajs-2646	150	28	in	in	ADP
iajs-2646	150	29	women	woman	NOUN
iajs-2646	150	30	with	with	ADP
iajs-2646	150	31	and	and	CCONJ
iajs-2646	150	32	without	without	ADP
iajs-2646	150	33	rheumatoid	rheumatoid	NOUN
iajs-2646	150	34	arthritis	arthritis	NOUN
iajs-2646	150	35	.	.	PUNCT
iajs-2646	151	1	arthritis	arthritis	NOUN
iajs-2646	151	2	rheum	rheum	NOUN
iajs-2646	151	3	.	.	PUNCT
iajs-2646	152	1	2004	2004	NUM
iajs-2646	152	2	,	,	PUNCT
iajs-2646	152	3	50	50	NUM
iajs-2646	152	4	,	,	PUNCT
iajs-2646	152	5	11	11	NUM
iajs-2646	152	6	,	,	PUNCT
iajs-2646	152	7	3444	3444	NUM
iajs-2646	152	8	-	-	SYM
iajs-2646	152	9	3449	3449	NUM
iajs-2646	152	10	.	.	PUNCT
iajs-2646	153	1	16	16	NUM
iajs-2646	153	2	.	.	PUNCT
iajs-2646	153	3	toms	tom	NOUN
iajs-2646	153	4	,	,	PUNCT
iajs-2646	153	5	t.e	t.e	PROPN
iajs-2646	153	6	.	.	PROPN
iajs-2646	153	7	;	;	PUNCT
iajs-2646	153	8	symmons	symmon	NOUN
iajs-2646	153	9	,	,	PUNCT
iajs-2646	153	10	d.p	d.p	PROPN
iajs-2646	153	11	.	.	PROPN
iajs-2646	153	12	;	;	PUNCT
iajs-2646	153	13	kitas	kitas	PROPN
iajs-2646	153	14	,	,	PUNCT
iajs-2646	153	15	g.d	g.d	PROPN
iajs-2646	153	16	.	.	PROPN
iajs-2646	153	17	dyslipidaemia	dyslipidaemia	NOUN
iajs-2646	153	18	in	in	ADP
iajs-2646	153	19	rheumatoid	rheumatoid	NOUN
iajs-2646	153	20	arthritis	arthritis	NOUN
iajs-2646	153	21	:	:	PUNCT
iajs-2646	153	22	the	the	DET
iajs-2646	153	23	role	role	NOUN
iajs-2646	153	24	of	of	ADP
iajs-2646	153	25	inflammation	inflammation	NOUN
iajs-2646	153	26	,	,	PUNCT
iajs-2646	153	27	drugs	drug	NOUN
iajs-2646	153	28	,	,	PUNCT
iajs-2646	153	29	lifestyle	lifestyle	NOUN
iajs-2646	153	30	and	and	CCONJ
iajs-2646	153	31	genetic	genetic	ADJ
iajs-2646	153	32	factors	factor	NOUN
iajs-2646	153	33	.	.	PUNCT
iajs-2646	154	1	curr	curr	PROPN
iajs-2646	154	2	vasc	vasc	PROPN
iajs-2646	154	3	pharmacol	pharmacol	PROPN
iajs-2646	154	4	.	.	PUNCT
iajs-2646	155	1	2010	2010	NUM
iajs-2646	155	2	,	,	PUNCT
iajs-2646	155	3	8	8	NUM
iajs-2646	155	4	,	,	PUNCT
iajs-2646	155	5	3	3	NUM
iajs-2646	155	6	,	,	PUNCT
iajs-2646	155	7	301	301	NUM
iajs-2646	155	8	-	-	SYM
iajs-2646	155	9	326	326	NUM
iajs-2646	155	10	.	.	PUNCT
iajs-2646	156	1	17	17	NUM
iajs-2646	156	2	.	.	PUNCT
iajs-2646	157	1	solomon	solomon	PROPN
iajs-2646	157	2	,	,	PUNCT
iajs-2646	157	3	d.h	d.h	PROPN
iajs-2646	157	4	.	.	PROPN
iajs-2646	157	5	;	;	PUNCT
iajs-2646	157	6	kremer	kremer	PROPN
iajs-2646	157	7	,	,	PUNCT
iajs-2646	157	8	j.	j.	PROPN
iajs-2646	157	9	;	;	PUNCT
iajs-2646	157	10	curtis	curtis	PROPN
iajs-2646	157	11	,	,	PUNCT
iajs-2646	157	12	j.r	j.r	PROPN
iajs-2646	157	13	.	.	PROPN
iajs-2646	157	14	;	;	PUNCT
iajs-2646	157	15	hochberg	hochberg	PROPN
iajs-2646	157	16	,	,	PUNCT
iajs-2646	157	17	m.c	m.c	PROPN
iajs-2646	157	18	.	.	PROPN
iajs-2646	157	19	;	;	PUNCT
iajs-2646	157	20	reed	reed	PROPN
iajs-2646	157	21	,	,	PUNCT
iajs-2646	157	22	g.	g.	PROPN
iajs-2646	157	23	;	;	PUNCT
iajs-2646	157	24	tsao	tsao	PROPN
iajs-2646	157	25	,	,	PUNCT
iajs-2646	157	26	p.	p.	NOUN
iajs-2646	157	27	explaining	explain	VERB
iajs-2646	157	28	the	the	DET
iajs-2646	157	29	cardiovascular	cardiovascular	ADJ
iajs-2646	157	30	risk	risk	NOUN
iajs-2646	157	31	associated	associate	VERB
iajs-2646	157	32	with	with	ADP
iajs-2646	157	33	rheumatoid	rheumatoid	NOUN
iajs-2646	157	34	arthritis	arthritis	NOUN
iajs-2646	157	35	:	:	PUNCT
iajs-2646	157	36	traditional	traditional	ADJ
iajs-2646	157	37	risk	risk	NOUN
iajs-2646	157	38	factors	factor	NOUN
iajs-2646	157	39	versus	versus	ADP
iajs-2646	157	40	markers	marker	NOUN
iajs-2646	157	41	of	of	ADP
iajs-2646	157	42	rheumatoid	rheumatoid	VERB
iajs-2646	157	43	arthritis	arthritis	NOUN
iajs-2646	157	44	severity	severity	NOUN
iajs-2646	157	45	.	.	PUNCT
iajs-2646	158	1	ann	ann	PROPN
iajs-2646	158	2	rheum	rheum	PROPN
iajs-2646	158	3	dis	dis	PROPN
iajs-2646	158	4	.	.	PUNCT
iajs-2646	159	1	2010	2010	NUM
iajs-2646	159	2	,	,	PUNCT
iajs-2646	159	3	69	69	NUM
iajs-2646	159	4	,	,	PUNCT
iajs-2646	159	5	11	11	NUM
iajs-2646	159	6	,	,	PUNCT
iajs-2646	159	7	1920	1920	NUM
iajs-2646	159	8	-	-	SYM
iajs-2646	159	9	1925	1925	NUM
iajs-2646	159	10	.	.	PUNCT
iajs-2646	160	1	18	18	NUM
iajs-2646	160	2	.	.	PUNCT
iajs-2646	161	1	kremers	kremer	NOUN
iajs-2646	161	2	,	,	PUNCT
iajs-2646	161	3	h.m	h.m	PROPN
iajs-2646	161	4	.	.	PROPN
iajs-2646	161	5	;	;	PUNCT
iajs-2646	161	6	crowson	crowson	PROPN
iajs-2646	161	7	,	,	PUNCT
iajs-2646	161	8	c.s	c.s	PROPN
iajs-2646	161	9	.	.	PROPN
iajs-2646	161	10	;	;	PUNCT
iajs-2646	161	11	therneau	therneau	PROPN
iajs-2646	161	12	,	,	PUNCT
iajs-2646	161	13	t.m	t.m	PROPN
iajs-2646	161	14	.	.	PROPN
iajs-2646	161	15	;	;	PUNCT
iajs-2646	161	16	roger	roger	PROPN
iajs-2646	161	17	,	,	PUNCT
iajs-2646	161	18	v.l	v.l	PROPN
iajs-2646	161	19	.	.	PROPN
iajs-2646	161	20	;	;	PUNCT
iajs-2646	161	21	gabriel	gabriel	PROPN
iajs-2646	161	22	,	,	PUNCT
iajs-2646	161	23	s.e	s.e	PROPN
iajs-2646	161	24	.	.	PROPN
iajs-2646	161	25	high	high	ADJ
iajs-2646	161	26	ten	ten	NUM
iajs-2646	161	27	-	-	PUNCT
iajs-2646	161	28	year	year	NOUN
iajs-2646	161	29	risk	risk	NOUN
iajs-2646	161	30	of	of	ADP
iajs-2646	161	31	cardiovascular	cardiovascular	ADJ
iajs-2646	161	32	disease	disease	NOUN
iajs-2646	161	33	in	in	ADP
iajs-2646	161	34	newly	newly	ADV
iajs-2646	161	35	diagnosed	diagnose	VERB
iajs-2646	161	36	rheumatoid	rheumatoid	NOUN
iajs-2646	161	37	arthritis	arthritis	NOUN
iajs-2646	161	38	patients	patient	NOUN
iajs-2646	161	39	:	:	PUNCT
iajs-2646	161	40	a	a	DET
iajs-2646	161	41	population	population	NOUN
iajs-2646	161	42	-	-	PUNCT
iajs-2646	161	43	based	base	VERB
iajs-2646	161	44	cohort	cohort	NOUN
iajs-2646	161	45	study	study	NOUN
iajs-2646	161	46	.	.	PUNCT
iajs-2646	162	1	arthritis	arthritis	NOUN
iajs-2646	162	2	rheum	rheum	NOUN
iajs-2646	162	3	.	.	PUNCT
iajs-2646	163	1	2008	2008	NUM
iajs-2646	163	2	,	,	PUNCT
iajs-2646	163	3	58	58	NUM
iajs-2646	163	4	,	,	PUNCT
iajs-2646	163	5	8	8	NUM
iajs-2646	163	6	,	,	PUNCT
iajs-2646	163	7	2268	2268	NUM
iajs-2646	163	8	-	-	SYM
iajs-2646	163	9	2274	2274	NUM
iajs-2646	163	10	.	.	PUNCT
iajs-2646	164	1	19	19	NUM
iajs-2646	164	2	.	.	X
iajs-2646	164	3	avina	avina	PROPN
iajs-2646	164	4	-	-	PUNCT
iajs-2646	164	5	zubieta	zubieta	PROPN
iajs-2646	164	6	,	,	PUNCT
iajs-2646	164	7	j.a	j.a	PROPN
iajs-2646	164	8	.	.	PROPN
iajs-2646	164	9	;	;	PUNCT
iajs-2646	164	10	choi	choi	NOUN
iajs-2646	164	11	,	,	PUNCT
iajs-2646	164	12	h.k	h.k	PROPN
iajs-2646	164	13	.	.	PROPN
iajs-2646	164	14	;	;	PUNCT
iajs-2646	164	15	sadatsafavi	sadatsafavi	VERB
iajs-2646	164	16	,	,	PUNCT
iajs-2646	164	17	m.	m.	NOUN
iajs-2646	164	18	;	;	PUNCT
iajs-2646	164	19	etminan	etminan	NUM
iajs-2646	164	20	,	,	PUNCT
iajs-2646	164	21	m.	m.	NOUN
iajs-2646	164	22	;	;	PUNCT
iajs-2646	164	23	esdaile	esdaile	ADJ
iajs-2646	164	24	,	,	PUNCT
iajs-2646	164	25	j.m	j.m	PROPN
iajs-2646	164	26	.	.	PROPN
iajs-2646	164	27	;	;	PUNCT
iajs-2646	164	28	lacaille	lacaille	NOUN
iajs-2646	164	29	,	,	PUNCT
iajs-2646	164	30	d.	d.	PROPN
iajs-2646	164	31	risk	risk	NOUN
iajs-2646	164	32	of	of	ADP
iajs-2646	164	33	cardiovascular	cardiovascular	ADJ
iajs-2646	164	34	mortality	mortality	NOUN
iajs-2646	164	35	in	in	ADP
iajs-2646	164	36	patients	patient	NOUN
iajs-2646	164	37	with	with	ADP
iajs-2646	164	38	rheumatoid	rheumatoid	NOUN
iajs-2646	164	39	arthritis	arthritis	NOUN
iajs-2646	164	40	:	:	PUNCT
iajs-2646	164	41	a	a	DET
iajs-2646	164	42	meta	meta	ADJ
iajs-2646	164	43	-	-	PUNCT
iajs-2646	164	44	analysis	analysis	NOUN
iajs-2646	164	45	of	of	ADP
iajs-2646	164	46	observational	observational	ADJ
iajs-2646	164	47	studies	study	NOUN
iajs-2646	164	48	.	.	PUNCT
iajs-2646	165	1	arthritis	arthritis	NOUN
iajs-2646	165	2	rheum	rheum	NOUN
iajs-2646	165	3	.	.	PUNCT
iajs-2646	166	1	2008	2008	NUM
iajs-2646	166	2	59	59	NUM
iajs-2646	166	3	,	,	PUNCT
iajs-2646	166	4	12	12	NUM
iajs-2646	166	5	,	,	PUNCT
iajs-2646	166	6	1690	1690	NUM
iajs-2646	166	7	-	-	SYM
iajs-2646	166	8	1697	1697	NUM
iajs-2646	166	9	.	.	PUNCT
iajs-2646	167	1	20	20	NUM
iajs-2646	167	2	.	.	PUNCT
iajs-2646	167	3	park	park	PROPN
iajs-2646	167	4	,	,	PUNCT
iajs-2646	167	5	y.b	y.b	PROPN
iajs-2646	167	6	.	.	PROPN
iajs-2646	167	7	;	;	PUNCT
iajs-2646	167	8	lee	lee	PROPN
iajs-2646	167	9	,	,	PUNCT
iajs-2646	167	10	s.k	s.k	PROPN
iajs-2646	167	11	.	.	PROPN
iajs-2646	167	12	;	;	PUNCT
iajs-2646	167	13	lee	lee	PROPN
iajs-2646	167	14	,	,	PUNCT
iajs-2646	167	15	w.k	w.k	PROPN
iajs-2646	167	16	.	.	PROPN
iajs-2646	167	17	;	;	PUNCT
iajs-2646	168	1	suh	suh	PROPN
iajs-2646	168	2	,	,	PUNCT
iajs-2646	168	3	c.h	c.h	PROPN
iajs-2646	168	4	.	.	PROPN
iajs-2646	168	5	;	;	PUNCT
iajs-2646	168	6	lee	lee	PROPN
iajs-2646	168	7	,	,	PUNCT
iajs-2646	168	8	c.w	c.w	PROPN
iajs-2646	168	9	.	.	PROPN
iajs-2646	168	10	;	;	PUNCT
iajs-2646	168	11	lee	lee	PROPN
iajs-2646	168	12	,	,	PUNCT
iajs-2646	168	13	c.h	c.h	PROPN
iajs-2646	168	14	,	,	PUNCT
iajs-2646	168	15	.	.	PUNCT
iajs-2646	169	1	lipid	lipid	NOUN
iajs-2646	169	2	profiles	profile	NOUN
iajs-2646	169	3	in	in	ADP
iajs-2646	169	4	untreated	untreated	ADJ
iajs-2646	169	5	patients	patient	NOUN
iajs-2646	169	6	with	with	ADP
iajs-2646	169	7	rheumatoid	rheumatoid	NOUN
iajs-2646	169	8	arthritis	arthritis	NOUN
iajs-2646	169	9	.	.	PUNCT
iajs-2646	170	1	j.	j.	PROPN
iajs-2646	170	2	rheumatol	rheumatol	PROPN
iajs-2646	170	3	.	.	PUNCT
iajs-2646	171	1	1999	1999	NUM
iajs-2646	171	2	,	,	PUNCT
iajs-2646	171	3	26	26	NUM
iajs-2646	171	4	,	,	PUNCT
iajs-2646	171	5	8	8	NUM
iajs-2646	171	6	,	,	PUNCT
iajs-2646	171	7	1701	1701	NUM
iajs-2646	171	8	-	-	SYM
iajs-2646	171	9	1704	1704	NUM
iajs-2646	171	10	.	.	PUNCT
iajs-2646	172	1	21	21	NUM
iajs-2646	172	2	.	.	PUNCT
iajs-2646	172	3	boers	boer	NOUN
iajs-2646	172	4	,	,	PUNCT
iajs-2646	172	5	m.	m.	NOUN
iajs-2646	172	6	;	;	PUNCT
iajs-2646	172	7	nurmohamed	nurmohame	VERB
iajs-2646	172	8	,	,	PUNCT
iajs-2646	172	9	m.t	m.t	PROPN
iajs-2646	172	10	.	.	PROPN
iajs-2646	172	11	;	;	PUNCT
iajs-2646	172	12	doelman	doelman	NOUN
iajs-2646	172	13	,	,	PUNCT
iajs-2646	172	14	c.j	c.j	PROPN
iajs-2646	172	15	.	.	PROPN
iajs-2646	172	16	;	;	PUNCT
iajs-2646	172	17	lard	lard	NOUN
iajs-2646	172	18	,	,	PUNCT
iajs-2646	172	19	l.r	l.r	PROPN
iajs-2646	172	20	.	.	PROPN
iajs-2646	172	21	;	;	PUNCT
iajs-2646	172	22	verhoeven	verhoeven	PROPN
iajs-2646	172	23	,	,	PUNCT
iajs-2646	172	24	a.c	a.c	PROPN
iajs-2646	172	25	.	.	PROPN
iajs-2646	172	26	;	;	PUNCT
iajs-2646	172	27	voskuyl	voskuyl	NOUN
iajs-2646	172	28	.	.	PUNCT
iajs-2646	173	1	a.e	a.e	PROPN
iajs-2646	173	2	.	.	PROPN
iajs-2646	173	3	influence	influence	NOUN
iajs-2646	173	4	of	of	ADP
iajs-2646	173	5	glucocorticoids	glucocorticoid	NOUN
iajs-2646	173	6	and	and	CCONJ
iajs-2646	173	7	disease	disease	NOUN
iajs-2646	173	8	activity	activity	NOUN
iajs-2646	173	9	on	on	ADP
iajs-2646	173	10	total	total	ADJ
iajs-2646	173	11	and	and	CCONJ
iajs-2646	173	12	high	high	ADJ
iajs-2646	173	13	density	density	NOUN
iajs-2646	173	14	lipoprotein	lipoprotein	ADJ
iajs-2646	173	15	cholesterol	cholesterol	NOUN
iajs-2646	173	16	in	in	ADP
iajs-2646	173	17	patients	patient	NOUN
iajs-2646	173	18	with	with	ADP
iajs-2646	173	19	rheumatoid	rheumatoid	NOUN
iajs-2646	173	20	arthritis	arthritis	NOUN
iajs-2646	173	21	.	.	PUNCT
iajs-2646	174	1	ann	ann	PROPN
iajs-2646	174	2	rheum	rheum	PROPN
iajs-2646	174	3	dis	dis	PROPN
iajs-2646	174	4	.	.	PUNCT
iajs-2646	175	1	2003	2003	NUM
iajs-2646	175	2	,	,	PUNCT
iajs-2646	175	3	62	62	NUM
iajs-2646	175	4	,	,	PUNCT
iajs-2646	175	5	9	9	NUM
iajs-2646	175	6	,	,	PUNCT
iajs-2646	175	7	842	842	NUM
iajs-2646	175	8	-	-	SYM
iajs-2646	175	9	845	845	NUM
iajs-2646	175	10	.	.	NOUN
iajs-2646	175	11	22	22	NUM
iajs-2646	175	12	.	.	PUNCT
iajs-2646	176	1	georgiadis	georgiadis	PROPN
iajs-2646	176	2	,	,	PUNCT
iajs-2646	176	3	a.n	a.n	PROPN
iajs-2646	176	4	.	.	PROPN
iajs-2646	176	5	;	;	PUNCT
iajs-2646	176	6	papavasiliou	papavasiliou	NOUN
iajs-2646	176	7	,	,	PUNCT
iajs-2646	176	8	e.c	e.c	PROPN
iajs-2646	176	9	.	.	PROPN
iajs-2646	176	10	;	;	PUNCT
iajs-2646	176	11	lourida	lourida	PROPN
iajs-2646	176	12	,	,	PUNCT
iajs-2646	176	13	e.s	e.s	PROPN
iajs-2646	176	14	.	.	PROPN
iajs-2646	176	15	;	;	PUNCT
iajs-2646	176	16	alamanos	alamanos	ADV
iajs-2646	176	17	,	,	PUNCT
iajs-2646	176	18	y.	y.	PRON
iajs-2646	176	19	;	;	PUNCT
iajs-2646	176	20	kostara	kostara	PROPN
iajs-2646	176	21	,	,	PUNCT
iajs-2646	176	22	c.	c.	NOUN
iajs-2646	176	23	;	;	PUNCT
iajs-2646	176	24	tselepis	tselepis	PROPN
iajs-2646	176	25	.	.	PUNCT
iajs-2646	177	1	a.d	a.d	PROPN
iajs-2646	177	2	.	.	PROPN
iajs-2646	177	3	atherogenic	atherogenic	ADJ
iajs-2646	177	4	lipid	lipid	NOUN
iajs-2646	177	5	profile	profile	NOUN
iajs-2646	177	6	is	be	AUX
iajs-2646	177	7	a	a	DET
iajs-2646	177	8	feature	feature	NOUN
iajs-2646	177	9	characteristic	characteristic	NOUN
iajs-2646	177	10	of	of	ADP
iajs-2646	177	11	patients	patient	NOUN
iajs-2646	177	12	with	with	ADP
iajs-2646	177	13	early	early	ADJ
iajs-2646	177	14	rheumatoid	rheumatoid	NOUN
iajs-2646	177	15	arthritis	arthritis	NOUN
iajs-2646	177	16	:	:	PUNCT
iajs-2646	177	17	effect	effect	NOUN
iajs-2646	177	18	of	of	ADP
iajs-2646	177	19	early	early	ADJ
iajs-2646	177	20	treatment	treatment	NOUN
iajs-2646	177	21	--	--	PUNCT
iajs-2646	177	22	a	a	DET
iajs-2646	177	23	prospective	prospective	ADJ
iajs-2646	177	24	,	,	PUNCT
iajs-2646	177	25	controlled	control	VERB
iajs-2646	177	26	study	study	NOUN
iajs-2646	177	27	.	.	PUNCT
iajs-2646	178	1	arthritis	arthritis	NOUN
iajs-2646	178	2	res	re	NOUN
iajs-2646	178	3	.	.	PUNCT
iajs-2646	179	1	ther	ther	PROPN
iajs-2646	179	2	.	.	PUNCT
iajs-2646	180	1	2006	2006	NUM
iajs-2646	180	2	,	,	PUNCT
iajs-2646	180	3	8	8	NUM
iajs-2646	180	4	,	,	PUNCT
iajs-2646	180	5	3	3	NUM
iajs-2646	180	6	,	,	PUNCT
iajs-2646	180	7	r82	r82	VERB
iajs-2646	180	8	.	.	PUNCT
iajs-2646	181	1	23	23	NUM
iajs-2646	181	2	.	.	PUNCT
iajs-2646	182	1	myasoedova	myasoedova	PROPN
iajs-2646	182	2	,	,	PUNCT
iajs-2646	182	3	e.	e.	PROPN
iajs-2646	182	4	;	;	PUNCT
iajs-2646	182	5	crowson	crowson	PROPN
iajs-2646	182	6	,	,	PUNCT
iajs-2646	182	7	c.s	c.s	PROPN
iajs-2646	182	8	.	.	PROPN
iajs-2646	182	9	;	;	PUNCT
iajs-2646	183	1	kremers	kremer	NOUN
iajs-2646	183	2	,	,	PUNCT
iajs-2646	183	3	h.m	h.m	PROPN
iajs-2646	183	4	.	.	PROPN
iajs-2646	183	5	;	;	PUNCT
iajs-2646	183	6	roger	roger	PROPN
iajs-2646	183	7	,	,	PUNCT
iajs-2646	183	8	v.l	v.l	PROPN
iajs-2646	183	9	.	.	PROPN
iajs-2646	183	10	;	;	PUNCT
iajs-2646	183	11	fitz	fitz	PROPN
iajs-2646	183	12	-	-	PUNCT
iajs-2646	183	13	gibbon	gibbon	PROPN
iajs-2646	183	14	.	.	PUNCT
iajs-2646	184	1	p.d	p.d	PROPN
iajs-2646	184	2	.	.	PROPN
iajs-2646	184	3	;	;	PUNCT
iajs-2646	184	4	therneau	therneau	PROPN
iajs-2646	184	5	.	.	PUNCT
iajs-2646	185	1	t.m	t.m	PROPN
iajs-2646	185	2	.	.	PROPN
iajs-2646	185	3	lipid	lipid	PROPN
iajs-2646	185	4	paradox	paradox	NOUN
iajs-2646	185	5	in	in	ADP
iajs-2646	185	6	rheumatoid	rheumatoid	NOUN
iajs-2646	185	7	arthritis	arthritis	NOUN
iajs-2646	185	8	:	:	PUNCT
iajs-2646	185	9	the	the	DET
iajs-2646	185	10	impact	impact	NOUN
iajs-2646	185	11	of	of	ADP
iajs-2646	185	12	serum	serum	NOUN
iajs-2646	185	13	lipid	lipid	NOUN
iajs-2646	185	14	measures	measure	NOUN
iajs-2646	185	15	and	and	CCONJ
iajs-2646	185	16	systemic	systemic	ADJ
iajs-2646	185	17	inflammation	inflammation	NOUN
iajs-2646	185	18	on	on	ADP
iajs-2646	185	19	the	the	DET
iajs-2646	185	20	risk	risk	NOUN
iajs-2646	185	21	of	of	ADP
iajs-2646	185	22	cardiovascular	cardiovascular	ADJ
iajs-2646	185	23	disease	disease	NOUN
iajs-2646	185	24	.	.	PUNCT
iajs-2646	186	1	ann	ann	PROPN
iajs-2646	186	2	rheum	rheum	PROPN
iajs-2646	186	3	dis	dis	PROPN
iajs-2646	186	4	.	.	PUNCT
iajs-2646	187	1	2011	2011	NUM
iajs-2646	187	2	,	,	PUNCT
iajs-2646	187	3	70	70	NUM
iajs-2646	187	4	,	,	PUNCT
iajs-2646	187	5	3	3	NUM
iajs-2646	187	6	,	,	PUNCT
iajs-2646	187	7	482	482	NUM
iajs-2646	187	8	-	-	SYM
iajs-2646	187	9	487	487	NUM
iajs-2646	187	10	.	.	PUNCT
iajs-2646	188	1	24	24	NUM
iajs-2646	188	2	.	.	PUNCT
iajs-2646	189	1	van	van	PROPN
iajs-2646	189	2	halm	halm	PROPN
iajs-2646	189	3	,	,	PUNCT
iajs-2646	189	4	v.p	v.p	PROPN
iajs-2646	189	5	.	.	PROPN
iajs-2646	189	6	;	;	PUNCT
iajs-2646	189	7	nielen	nielen	PROPN
iajs-2646	189	8	,	,	PUNCT
iajs-2646	189	9	m.m	m.m	PROPN
iajs-2646	189	10	.	.	PROPN
iajs-2646	189	11	;	;	PUNCT
iajs-2646	189	12	nurmohamed	nurmohame	VERB
iajs-2646	189	13	,	,	PUNCT
iajs-2646	189	14	m.t	m.t	PROPN
iajs-2646	189	15	.	.	PROPN
iajs-2646	189	16	;	;	PUNCT
iajs-2646	189	17	van	van	PROPN
iajs-2646	189	18	schaardenburg	schaardenburg	PROPN
iajs-2646	189	19	,	,	PUNCT
iajs-2646	189	20	d.	d.	PROPN
iajs-2646	189	21	;	;	PUNCT
iajs-2646	189	22	reesink	reesink	VERB
iajs-2646	189	23	.	.	PUNCT
iajs-2646	190	1	h.w	h.w	PROPN
iajs-2646	190	2	.	.	PROPN
iajs-2646	190	3	;	;	PUNCT
iajs-2646	190	4	voskuyl	voskuyl	NOUN
iajs-2646	190	5	,	,	PUNCT
iajs-2646	190	6	a.e	a.e	PROPN
iajs-2646	190	7	.	.	PROPN
iajs-2646	190	8	lipids	lipids	PROPN
iajs-2646	190	9	and	and	CCONJ
iajs-2646	190	10	inflammation	inflammation	NOUN
iajs-2646	190	11	:	:	PUNCT
iajs-2646	190	12	serial	serial	ADJ
iajs-2646	190	13	measurements	measurement	NOUN
iajs-2646	190	14	of	of	ADP
iajs-2646	190	15	the	the	DET
iajs-2646	190	16	lipid	lipid	NOUN
iajs-2646	190	17	profile	profile	NOUN
iajs-2646	190	18	of	of	ADP
iajs-2646	190	19	blood	blood	NOUN
iajs-2646	190	20	donors	donor	NOUN
iajs-2646	190	21	who	who	PRON
iajs-2646	190	22	later	later	ADV
iajs-2646	190	23	developed	develop	VERB
iajs-2646	190	24	rheumatoid	rheumatoid	NOUN
iajs-2646	190	25	arthritis	arthritis	NOUN
iajs-2646	190	26	.	.	PUNCT
iajs-2646	191	1	ann	ann	PROPN
iajs-2646	191	2	rheum	rheum	PROPN
iajs-2646	191	3	dis	dis	PROPN
iajs-2646	191	4	.	.	PUNCT
iajs-2646	192	1	2007	2007	NUM
iajs-2646	192	2	,	,	PUNCT
iajs-2646	192	3	66	66	NUM
iajs-2646	192	4	,	,	PUNCT
iajs-2646	192	5	2	2	NUM
iajs-2646	192	6	,	,	PUNCT
iajs-2646	192	7	184188	184188	NUM
iajs-2646	192	8	.	.	PUNCT
iajs-2646	193	1	25	25	NUM
iajs-2646	193	2	.	.	PUNCT
iajs-2646	193	3	solomon	solomon	PROPN
iajs-2646	193	4	,	,	PUNCT
iajs-2646	193	5	d.h	d.h	PROPN
iajs-2646	193	6	.	.	PROPN
iajs-2646	193	7	;	;	PUNCT
iajs-2646	193	8	goodson	goodson	PROPN
iajs-2646	193	9	,	,	PUNCT
iajs-2646	193	10	n.j	n.j	PROPN
iajs-2646	193	11	.	.	PROPN
iajs-2646	193	12	;	;	PUNCT
iajs-2646	193	13	katz	katz	PROPN
iajs-2646	193	14	,	,	PUNCT
iajs-2646	193	15	j.n	j.n	PROPN
iajs-2646	193	16	.	.	PROPN
iajs-2646	193	17	;	;	PUNCT
iajs-2646	193	18	weinblatt	weinblatt	PROPN
iajs-2646	193	19	,	,	PUNCT
iajs-2646	193	20	m.e	m.e	PROPN
iajs-2646	193	21	.	.	PROPN
iajs-2646	193	22	;	;	PUNCT
iajs-2646	193	23	avorn	avorn	PROPN
iajs-2646	193	24	,	,	PUNCT
iajs-2646	193	25	j.	j.	PROPN
iajs-2646	193	26	;	;	PUNCT
iajs-2646	193	27	setoguchi	setoguchi	PROPN
iajs-2646	193	28	,	,	PUNCT
iajs-2646	193	29	s.	s.	PROPN
iajs-2646	193	30	patterns	pattern	NOUN
iajs-2646	193	31	of	of	ADP
iajs-2646	193	32	cardiovascular	cardiovascular	ADJ
iajs-2646	193	33	risk	risk	NOUN
iajs-2646	193	34	in	in	ADP
iajs-2646	193	35	rheumatoid	rheumatoid	NOUN
iajs-2646	193	36	arthritis	arthritis	NOUN
iajs-2646	193	37	.	.	PUNCT
iajs-2646	194	1	ann	ann	PROPN
iajs-2646	194	2	rheum	rheum	PROPN
iajs-2646	194	3	dis	dis	PROPN
iajs-2646	194	4	.	.	PUNCT
iajs-2646	195	1	2006,65	2006,65	NUM
iajs-2646	195	2	,	,	PUNCT
iajs-2646	195	3	12	12	NUM
iajs-2646	195	4	,	,	PUNCT
iajs-2646	195	5	16081612	16081612	NUM
iajs-2646	195	6	.	.	PUNCT
iajs-2646	196	1	http://ihicps.com/	http://ihicps.com/	NOUN